Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2020);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;9.921;Q1;328;247;676;7946;8550;314;12.38;32.17;United Kingdom;Western Europe;Nature Publishing Group;2002-2020;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;8.176;Q1;231;26;65;10316;1524;65;24.79;396.77;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2020;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;4700152457;Nano Today;journal;17480132;5.586;Q1;143;128;154;15010;2971;154;19.49;117.27;Netherlands;Western Europe;Elsevier;1970, 2006-2020;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
4;21100466864;Journal for ImmunoTherapy of Cancer;journal;20511426;5.060;Q1;61;519;584;19214;6888;573;11.37;37.02;United Kingdom;Western Europe;BMJ Publishing Group;2013-2020;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)"
5;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;4.968;Q1;204;33;90;4408;1233;90;12.63;133.58;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2020;"Pharmacology (Q1); Toxicology (Q1)"
6;12611;Drug Resistance Updates;journal;13687646, 15322084;4.010;Q1;110;28;52;6414;835;52;17.23;229.07;United States;Northern America;Churchill Livingstone;1998-2020;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;3.878;Q1;218;101;288;6920;3178;276;9.93;68.51;United Kingdom;Western Europe;Elsevier Ltd.;1979-2020;"Pharmacology (Q1); Toxicology (Q1)"
8;12455;Molecular Therapy;journal;15250024, 15250016;3.871;Q1;174;226;745;10674;6849;693;8.33;47.23;United States;Northern America;Cell Press;2000-2020;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
9;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;3.475;Q1;313;138;485;28532;6945;443;13.23;206.75;Netherlands;Western Europe;Elsevier;1987-2020;Pharmaceutical Science (Q1)
10;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;3.461;Q1;201;162;450;33410;5374;450;11.45;206.23;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
11;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.364;Q1;182;155;527;9497;3601;518;6.52;61.27;United States;Northern America;Elsevier Inc.;2016-2020;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
12;19600166320;Protein and Cell;journal;16748018, 1674800X;2.973;Q1;63;132;313;6672;1862;198;6.17;50.55;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;2010-2020;"Biochemistry (Q1); Biotechnology (Q1); Cell Biology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
13;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;2.928;Q1;223;320;878;35862;7263;869;8.46;112.07;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2020;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.868;Q1;130;105;162;22297;1985;157;12.11;212.35;United States;Northern America;John Wiley and Sons Inc.;1981-2020;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;2.704;Q1;219;310;913;18081;5570;830;5.66;58.33;United Kingdom;Western Europe;Nature Publishing Group;1987-2020;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
16;26371;Natural Product Reports;journal;02650568, 14604752;2.703;Q1;177;92;246;12696;2233;239;8.45;138.00;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2020;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
17;21100850730;npj Vaccines;journal;20590105;2.691;Q1;22;105;134;5357;866;133;6.12;51.02;United Kingdom;Western Europe;Nature Publishing Group;2016-2020;"Immunology (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
18;21100207003;Theranostics;journal;18387640;2.689;Q1;97;849;1358;57817;14693;1337;10.67;68.10;Australia;Pacific Region;Ivyspring International Publisher;2012-2020;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
19;18148;Pain;journal;18726623, 03043959;2.524;Q1;258;310;944;6532;5172;808;5.32;21.07;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2020;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
20;5100155080;Neurotherapeutics;journal;19337213;2.496;Q1;114;191;296;16419;2063;266;6.31;85.96;United States;Northern America;Springer New York;2007-2020;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
21;21100232818;Emerging Microbes and Infections;journal;22221751;2.475;Q1;53;302;493;10153;2841;414;5.84;33.62;United Kingdom;Western Europe;Nature Publishing Group;2012-2020;"Drug Discovery (Q1); Epidemiology (Q1); Immunology (Q1); Infectious Diseases (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Parasitology (Q1); Virology (Q1)"
22;20084;British Journal of Pharmacology;journal;14765381, 00071188;2.432;Q1;211;424;1024;32143;7872;967;7.34;75.81;United States;Northern America;Wiley-Blackwell;1965-2020;Pharmacology (Q1)
23;21100819608;Emerging Contaminants;journal;24056650, 24056642;2.343;Q1;18;45;53;2928;480;52;3.92;65.07;China;Asiatic Region;KeAi Publishing Communications Ltd.;2015-2020;"Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
24;21100225611;Advanced healthcare materials;journal;21922640, 21922659;2.288;Q1;90;348;997;27947;8661;977;8.78;80.31;United Kingdom;Western Europe;John Wiley and Sons Ltd;2012-2020;"Biomaterials (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1)"
25;21101018849;ACS Pharmacology and Translational Science;journal;25759108;2.271;Q1;10;134;64;8637;224;56;3.50;64.46;United States;Northern America;American Chemical Society;2018-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
26;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;2.255;Q1;67;38;115;1567;594;113;4.92;41.24;United States;Northern America;Mary Ann Liebert Inc.;2011-2020;"Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)"
27;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;2.208;Q1;59;384;671;18962;5334;666;8.20;49.38;United States;Northern America;Cell Press;2012-2020;"Drug Discovery (Q1); Molecular Medicine (Q1)"
28;23916;Environmental Pollution;journal;02697491, 18736424;2.136;Q1;227;2109;4204;129684;35383;4169;8.04;61.49;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2020;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
29;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.124;Q1;194;529;1711;15238;8229;1497;4.64;28.81;United Kingdom;Western Europe;Oxford University Press;1975-2020;"Infectious Diseases (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
30;23010;Journal of Controlled Release;journal;18734995, 01683659;2.119;Q1;269;542;1475;46989;12990;1397;8.66;86.70;Netherlands;Western Europe;Elsevier;1984-2020;Pharmaceutical Science (Q1)
31;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.070;Q1;259;747;2639;26789;12822;2505;4.45;35.86;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2020;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
32;19617;Antiviral Research;journal;01663542, 18729096;2.052;Q1;124;212;683;10684;4045;683;5.87;50.40;Netherlands;Western Europe;Elsevier;1959, 1981-2020;"Pharmacology (Q1); Virology (Q1)"
33;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.010;Q1;261;909;2124;60881;14452;2110;6.84;66.98;United States;Northern America;American Chemical Society;1959-1961, 1963-2020;"Drug Discovery (Q1); Molecular Medicine (Q1)"
34;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;1.990;Q1;135;965;2482;46225;11656;2436;4.33;47.90;United States;Northern America;Public Library of Science;2007-2020;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
35;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.964;Q1;89;104;289;12174;1585;255;5.27;117.06;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2020;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
36;14990;Current Neuropharmacology;journal;18756190, 1570159X;1.955;Q1;73;78;285;11625;1968;261;6.47;149.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2020;"Medicine (miscellaneous) (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
37;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;1.941;Q1;188;404;930;13378;4078;685;4.03;33.11;United States;Northern America;Wiley-Blackwell;1960-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
38;20051;BioDrugs;journal;11738804, 1179190X;1.919;Q1;67;62;166;4406;942;151;4.68;71.06;United Kingdom;Western Europe;Adis International Ltd;1997-2020;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
39;20700195026;Acta Pharmaceutica Sinica B;journal;22113843, 22113835;1.912;Q1;51;202;278;15419;2616;262;10.62;76.33;Netherlands;Western Europe;Elsevier BV;2012, 2014-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
40;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.897;Q1;107;52;308;3134;1580;298;4.81;60.27;United Kingdom;Western Europe;Oxford University Press;1998-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
41;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;1.868;Q1;132;109;343;6638;1728;306;4.81;60.90;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
42;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.864;Q1;86;94;314;8262;1570;289;4.79;87.89;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2020;"Drug Discovery (Q1); Immunology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
43;21169;Pharmacological Research;journal;10436618, 10961186;1.850;Q1;132;602;1051;58732;7205;974;6.78;97.56;United States;Northern America;Academic Press Inc.;1989-2020;Pharmacology (Q1)
44;21165;PharmacoEconomics;journal;11707690, 11792027;1.809;Q1;100;113;361;4891;1373;316;3.76;43.28;United Kingdom;Western Europe;Adis International Ltd;1992-2020;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
45;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.805;Q1;92;45;149;1329;697;149;4.30;29.53;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2020;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
46;26380;Drug and Alcohol Dependence;journal;03768716;1.783;Q1;166;542;1408;24733;6169;1399;4.07;45.63;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
47;21196;Drug Discovery Today;journal;18785832, 13596446;1.778;Q1;175;258;667;19752;5142;630;7.17;76.56;United Kingdom;Western Europe;Elsevier Ltd.;1996-2020;"Drug Discovery (Q1); Pharmacology (Q1)"
48;20435;Neuropharmacology;journal;00283908, 18737064;1.760;Q1;167;419;1335;35191;6833;1309;4.79;83.99;United Kingdom;Western Europe;Elsevier Ltd.;1962-2020;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
49;21100875801;npj Systems Biology and Applications;journal;20567189;1.752;Q1;21;33;115;1694;496;115;4.33;51.33;United Kingdom;Western Europe;Nature Publishing Group;2015-2020;"Applied Mathematics (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Computer Science Applications (Q1); Drug Discovery (Q1); Modeling and Simulation (Q1)"
50;4400151524;Particle and Fibre Toxicology;journal;17438977;1.748;Q1;98;61;145;4821;1251;143;8.45;79.03;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2020;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
51;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.716;Q1;127;254;751;19836;3615;740;4.80;78.09;United States;Northern America;Elsevier Inc.;1982-2021;"Pharmacology (Q1); Biological Psychiatry (Q2)"
52;15984;Journal of Molecular Medicine;journal;09462716, 14321440;1.708;Q1;139;139;369;9431;1791;350;4.06;67.85;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2020;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
53;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;1.684;Q1;50;70;188;3450;1018;174;5.52;49.29;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2020;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
54;21207;Drug Discovery Today: Technologies;journal;17406749;1.676;Q1;51;16;99;1002;521;89;5.64;62.63;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Biotechnology (Q1); Drug Discovery (Q1); Molecular Medicine (Q1)"
55;16088;Journal of Nanobiotechnology;journal;14773155;1.629;Q1;76;173;315;9891;2936;313;9.46;57.17;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2020;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
56;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.605;Q1;90;104;380;10866;1279;30;2.97;104.48;Germany;Western Europe;Springer Heidelberg;2004-2020;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
57;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.603;Q1;112;154;383;9717;1610;371;3.85;63.10;Netherlands;Western Europe;Elsevier;1990-2020;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
58;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.595;Q1;198;513;993;40185;5594;983;5.29;78.33;United States;Northern America;Elsevier Inc.;1958-2020;"Biochemistry (Q1); Pharmacology (Q1)"
59;21100857212;Current Opinion in Systems Biology;journal;24523100;1.576;Q1;21;43;269;2736;800;239;2.90;63.63;United Kingdom;Western Europe;Elsevier Ltd.;2017-2020;"Applied Mathematics (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Computer Science Applications (Q1); Drug Discovery (Q1); Modeling and Simulation (Q1)"
60;144771;Clinical Trials;journal;17407753, 17407745;1.559;Q1;63;94;256;2248;537;214;1.85;23.91;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2020;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
61;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.549;Q1;164;130;363;6801;1831;330;4.86;52.32;United Kingdom;Western Europe;Adis International Ltd;1976-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
62;24763;Addictive Behaviors;journal;03064603;1.520;Q1;127;345;1180;16254;4787;1148;3.56;47.11;United Kingdom;Western Europe;Elsevier Ltd.;1975-2021;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
63;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;1.514;Q1;90;240;504;13463;2900;496;5.19;56.10;United Kingdom;Western Europe;Nature Publishing Group;1980-2020;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
64;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.513;Q1;83;16;53;2147;340;49;5.43;134.19;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2020;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
65;22378;Vascular Pharmacology;journal;18793649, 15371891;1.479;Q1;95;48;205;2358;1033;203;5.31;49.13;United States;Northern America;Elsevier Inc.;2002-2020;"Molecular Medicine (Q1); Pharmacology (Q1); Physiology (Q1)"
66;19963;Molecular Pharmacology;journal;15210111, 0026895X;1.469;Q1;198;118;399;6604;1537;397;3.94;55.97;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2020;"Molecular Medicine (Q1); Pharmacology (Q1)"
67;24749;Addiction Biology;journal;13556215, 13691600;1.445;Q1;78;209;367;11240;1489;363;3.65;53.78;United States;Northern America;Wiley-Blackwell;1996-2020;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
68;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.421;Q1;38;85;159;2054;340;140;1.92;24.16;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q1)"
69;145164;Human Genomics;journal;14739542, 14797364;1.414;Q1;55;44;151;2229;598;149;3.91;50.66;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2020;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
70;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.410;Q1;104;140;336;11558;1610;321;4.84;82.56;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2020;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
71;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.403;Q1;69;133;375;6105;1643;329;4.12;45.90;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1); Physiology (medical) (Q1); Psychiatry and Mental Health (Q1)"
72;21100214102;Frontiers in Pharmacology;journal;16639812;1.384;Q1;86;2224;3923;146755;21508;3857;5.33;65.99;Switzerland;Western Europe;Frontiers Media S.A.;2010-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
73;21782;Psychopharmacology;journal;00333158, 14322072;1.378;Q1;196;307;886;18421;3364;854;3.97;60.00;Germany;Western Europe;Springer Verlag;1959-2020;Pharmacology (Q1)
74;21237;Drug Safety;journal;01145916, 11791942;1.377;Q1;124;127;373;5207;1399;314;3.98;41.00;United Kingdom;Western Europe;Adis International Ltd;1990-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
75;25218;Toxicological Sciences;journal;10960929, 10966080;1.352;Q1;183;196;847;11031;3573;789;4.21;56.28;United Kingdom;Western Europe;Oxford University Press;1981-2020;Toxicology (Q1)
76;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.333;Q1;114;153;445;10164;1721;429;3.68;66.43;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2020;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
77;28620;Biomedicine and Pharmacotherapy;journal;07533322;1.323;Q1;92;1311;4853;81223;28759;4836;6.11;61.95;France;Western Europe;Elsevier Masson;1982-2020;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
78;4200151509;Molecular Diagnosis and Therapy;journal;11771062;1.322;Q1;42;62;191;4016;713;183;3.53;64.77;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2020;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
79;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.318;Q1;110;68;258;3690;1222;251;3.69;54.26;Netherlands;Western Europe;Springer Netherlands;1996-2020;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
80;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;1.316;Q1;61;130;319;13242;1685;266;4.60;101.86;United Kingdom;Western Europe;Informa Healthcare;2006-2020;Drug Discovery (Q1)
81;21100904379;Nanotheranostics;journal;22067418;1.310;Q1;16;22;89;1065;483;88;4.93;48.41;Australia;Pacific Region;Ivyspring International Publishers;2017-2020;"Biomedical Engineering (Q1); Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
82;19700174918;Clinical and Translational Science;journal;17528062, 17528054;1.303;Q1;44;174;228;5945;815;193;3.56;34.17;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2020;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q2)"
83;21100335701;Vaccines;journal;2076393X;1.296;Q1;37;780;343;49148;1485;332;4.13;63.01;Switzerland;Western Europe;MDPI Multidisciplinary Digital Publishing Institute;2013-2020;"Drug Discovery (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Immunology (Q2)"
84;17700156714;Pharmaceuticals;journal;14248247;1.295;Q1;59;482;414;37477;2273;403;5.68;77.75;Switzerland;Western Europe;MDPI Multidisciplinary Digital Publishing Institute;2009-2020;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
85;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.286;Q1;225;184;675;9818;2624;666;3.55;53.36;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2020;"Pharmacology (Q1); Molecular Medicine (Q2)"
86;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.279;Q1;172;279;1068;16082;4943;1053;4.47;57.64;United States;Northern America;American Chemical Society;1990-2020;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
87;20578;Journal of Food and Drug Analysis;journal;10219498;1.277;Q1;54;51;350;3112;2328;348;6.06;61.02;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2020;"Food Science (Q1); Pharmacology (Q1)"
88;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.267;Q1;153;254;730;13877;2257;675;2.82;54.63;United States;Northern America;Wiley-Blackwell;1977-2020;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
89;24604;Archives of Toxicology;journal;14320738, 03405761;1.264;Q1;111;294;826;19945;3996;723;4.21;67.84;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2020;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
90;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.263;Q1;125;191;695;10362;4177;689;5.91;54.25;United States;Northern America;Elsevier Inc.;2005-2020;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
91;4700152278;Drugs in Context;journal;17404398, 17451981;1.262;Q1;18;61;107;2847;561;107;5.69;46.67;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2020;"Pharmacology (Q1); Molecular Medicine (Q2)"
92;22477;Investigational New Drugs;journal;01676997, 15730646;1.254;Q1;87;196;366;6445;1308;364;3.27;32.88;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
93;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;1.245;Q1;128;681;1919;40894;12698;1913;5.93;60.05;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2020;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Nanoscience and Nanotechnology (Q2)"
94;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.219;Q1;70;94;163;8120;599;150;3.15;86.38;United States;Northern America;Springer New York;2006-2020;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2); Neuroscience (miscellaneous) (Q2)"
95;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.216;Q1;146;366;947;14447;3232;796;3.19;39.47;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
96;20770;Drug Delivery;journal;10717544, 15210464;1.189;Q1;65;154;501;8018;3107;501;6.08;52.06;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2020;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
97;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.184;Q1;135;152;366;11624;1232;361;3.31;76.47;United States;Northern America;Elsevier Inc.;1973-2020;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
98;19700201201;EPMA Journal;journal;18785077, 18785085;1.177;Q1;34;39;108;4020;658;106;6.37;103.08;United Kingdom;Western Europe;BioMed Central Ltd.;2010-2020;"Biochemistry (medical) (Q1); Drug Discovery (Q1); Health Policy (Q1)"
99;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;1.177;Q1;162;838;2853;56099;17278;2851;6.18;66.94;France;Western Europe;Elsevier Masson SAS;1974-2020;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
100;5400152706;Nanotoxicology;journal;17435390, 17435404;1.176;Q1;87;92;260;5547;1590;257;5.47;60.29;United Kingdom;Western Europe;Informa Healthcare;2007-2020;"Biomedical Engineering (Q1); Toxicology (Q1); Nanoscience and Nanotechnology (Q2)"
101;21100788744;OpenNano;journal;23529520;1.168;Q1;12;0;20;0;185;20;9.08;0.00;United States;Northern America;Elsevier Inc.;2016-2019;"Biotechnology (Q1); Internal Medicine (Q1); Pharmaceutical Science (Q1); Pharmacology (medical) (Q1)"
102;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.166;Q1;113;147;427;5437;1748;423;4.11;36.99;United States;Northern America;Landes Bioscience;2002-2020;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2); Oncology (Q2)"
103;4700152848;PPAR Research;journal;16874757, 16874765;1.164;Q1;49;29;57;2019;251;56;3.72;69.62;United States;Northern America;Hindawi Publishing Corporation;2006-2020;"Drug Discovery (Q1); Pharmacology (medical) (Q1)"
104;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.161;Q1;76;106;319;2853;1010;299;2.94;26.92;United States;Northern America;Preston Publications;1977-2020;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Environmental Chemistry (Q2)"
105;21100892509;Cannabis and Cannabinoid Research;journal;23788763;1.156;Q1;17;39;61;1733;274;57;4.50;44.44;United States;Northern America;Mary Ann Liebert Inc.;2016-2020;"Complementary and Alternative Medicine (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
106;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.155;Q1;92;115;232;5126;1030;227;4.57;44.57;United Kingdom;Western Europe;Nature Publishing Group;2006-2020;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
107;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.153;Q1;217;1056;2544;58542;14707;2532;5.72;55.44;Netherlands;Western Europe;Elsevier;1978-2020;Pharmaceutical Science (Q1)
108;22432;International Immunopharmacology;journal;18781705, 15675769;1.152;Q1;112;996;1536;50138;7199;1529;4.56;50.34;Netherlands;Western Europe;Elsevier;2001-2020;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
109;20473;Life Sciences;journal;18790631, 00243205;1.131;Q1;164;1283;1885;79494;8645;1883;4.66;61.96;United States;Northern America;Elsevier Inc.;1962-2020;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
110;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.130;Q1;127;408;1443;22045;7084;1430;4.69;54.03;United States;Northern America;American Chemical Society;2004-2020;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
111;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;1.126;Q1;63;222;452;4966;1234;430;2.37;22.37;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2020;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
112;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;1.121;Q1;71;73;253;6838;1413;243;6.11;93.67;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2020;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
113;22410;Inflammation Research;journal;1420908X, 10233830;1.121;Q1;89;116;294;6165;1216;289;4.11;53.15;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2020;"Pharmacology (Q1); Immunology (Q2)"
114;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.112;Q1;111;198;747;6622;2309;733;2.93;33.44;Germany;Western Europe;Springer Verlag;1978-2020;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
115;4000148019;AAPS Journal;journal;15507416;1.109;Q1;112;139;385;5759;1515;370;3.57;41.43;United States;Northern America;Springer New York;1999-2020;Pharmaceutical Science (Q1)
116;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.108;Q1;69;157;214;7808;779;189;2.77;49.73;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2020;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
117;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.105;Q1;35;53;151;1726;508;139;3.51;32.57;Japan;Asiatic Region;Springer Japan;2006-2020;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
118;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.103;Q1;158;259;849;14522;4755;844;5.35;56.07;Netherlands;Western Europe;Elsevier;1991-2020;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
119;21100258853;F1000Research;journal;20461402;1.099;Q1;60;634;2517;29738;6835;2435;2.30;46.91;United Kingdom;Western Europe;;2012-2020;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q2)"
120;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.092;Q1;111;53;125;5867;578;124;4.51;110.70;United Kingdom;Western Europe;Informa Healthcare;1971-2020;Toxicology (Q1)
121;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.088;Q1;86;176;426;13843;1577;394;3.63;78.65;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2020;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
122;84948;Expert Opinion on Drug Delivery;journal;17425247;1.084;Q1;107;152;320;14474;1821;291;5.79;95.22;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2020;Pharmaceutical Science (Q1)
123;10900153302;Biomarker Insights;journal;11772719;1.075;Q1;31;17;59;1317;270;58;5.50;77.47;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2020;"Biochemistry (medical) (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
124;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;1.071;Q1;34;52;162;3156;657;160;4.17;60.69;Netherlands;Western Europe;Elsevier BV;2011-2020;"Parasitology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Infectious Diseases (Q2)"
125;25219;Toxicology;journal;0300483X, 18793185;1.067;Q1;160;155;507;8548;2248;495;3.84;55.15;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2020;Toxicology (Q1)
126;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.066;Q1;92;108;195;3458;501;192;2.52;32.02;United States;Northern America;American Psychological Association Inc.;1993-2020;"Pharmacology (Q1); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
127;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.065;Q1;66;383;762;10498;2917;727;3.68;27.41;United States;Northern America;American Chemical Society;2010-2020;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
128;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;1.065;Q1;54;186;567;6239;1701;533;2.94;33.54;United Kingdom;Western Europe;John Wiley and Sons Ltd;2009-2020;"Analytical Chemistry (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1); Environmental Chemistry (Q2)"
129;18073;NeuroToxicology;journal;18729711, 0161813X;1.060;Q1;115;166;492;8829;1897;455;3.98;53.19;Netherlands;Western Europe;Elsevier;1979-2020;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
130;19700188360;Pharmaceutics;journal;19994923;1.054;Q1;50;1239;1030;86742;6540;1021;6.07;70.01;Switzerland;Western Europe;MDPI Multidisciplinary Digital Publishing Institute;2010-2020;Pharmaceutical Science (Q1)
131;19700178100;Nanotechnology, Science and Applications;journal;11778903;1.051;Q1;28;10;22;577;152;22;6.29;57.70;New Zealand;Pacific Region;Dove Medical Press Limited;2010-2012, 2014-2020;"Biomedical Engineering (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Nanoscience and Nanotechnology (Q2)"
132;19700188352;Toxins;journal;20726651;1.047;Q1;78;813;1707;43255;7233;1671;4.09;53.20;Switzerland;Western Europe;MDPI Multidisciplinary Digital Publishing Institute;2009-2020;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
133;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.046;Q1;180;668;1782;39724;7175;1779;4.12;59.47;Netherlands;Western Europe;Elsevier;1967-2020;Pharmacology (Q1)
134;17067;Phytomedicine;journal;09447113, 1618095X;1.045;Q1;120;239;915;12447;4556;904;5.04;52.08;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2020;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
135;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;1.043;Q1;58;539;1238;21736;3625;1022;2.80;40.33;United States;Northern America;Landes Bioscience;2012-2020;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
136;19700175015;Infection and Drug Resistance;journal;11786973;1.033;Q1;39;463;707;20129;2850;690;3.84;43.48;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2020;"Pharmacology (Q1); Infectious Diseases (Q2); Pharmacology (medical) (Q2)"
137;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.031;Q1;156;297;621;17847;2238;597;3.20;60.09;United States;Northern America;American Chemical Society;1988-2020;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
138;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;1.031;Q1;82;101;323;11570;1293;299;3.90;114.55;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2020;"Medicine (miscellaneous) (Q1); Toxicology (Q1); Pharmacology (Q2)"
139;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1.028;Q1;51;166;176;7896;575;154;3.36;47.57;United States;Northern America;Springer New York;2008-2020;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
140;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.026;Q1;125;106;344;4039;739;285;1.90;38.10;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2020;"Health (social science) (Q1); Toxicology (Q1); Psychiatry and Mental Health (Q2)"
141;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.025;Q1;175;144;513;6847;1751;507;3.39;47.55;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2020;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
142;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.023;Q1;97;32;78;4547;423;78;4.53;142.09;United States;Northern America;Informa Healthcare;1972-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
143;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876, 2221285X;1.021;Q1;39;70;190;5123;1087;188;6.24;73.19;China;Asiatic Region;Shenyang Pharmaceutical University;2009-2020;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
144;16573;Phytotherapy Research;journal;10991573, 0951418X;1.019;Q2;129;339;728;24548;3850;717;5.50;72.41;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2020;Pharmacology (Q2)
145;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.017;Q1;170;302;932;16368;3701;928;3.91;54.20;United States;Northern America;Academic Press Inc.;1959-2020;"Toxicology (Q1); Pharmacology (Q2)"
146;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;1.014;Q1;41;125;360;10841;1334;317;4.12;86.73;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2020;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
147;21100367469;Toxicology Reports;journal;22147500;1.013;Q1;37;197;388;10461;1977;382;4.81;53.10;Ireland;Western Europe;Elsevier Scientific Publishers Ireland;2014-2020;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
148;25240;Toxicology Letters;journal;03784274, 18793169;1.007;Q1;145;303;840;14151;3425;821;3.93;46.70;Netherlands;Western Europe;Elsevier BV;1977-2020;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
149;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.985;Q2;83;101;362;3788;1246;362;3.23;37.50;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2020;"Molecular Medicine (Q2); Pharmacology (Q2)"
150;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.977;Q1;36;65;220;3389;844;219;4.38;52.14;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2020;"Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
151;23053;Journal of Natural Products;journal;01633864, 15206025;0.976;Q1;139;432;1182;16488;4848;1170;3.82;38.17;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2020;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
152;26767;Altex;journal;1868596X, 18688551;0.975;Q2;51;64;151;1395;518;124;3.15;21.80;Germany;Western Europe;Springer International Publishing AG;2000-2020;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
153;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.975;Q2;48;42;78;4580;267;76;3.58;109.05;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2020;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
154;21100825823;Pharmacology Research and Perspectives;journal;20521707;0.975;Q1;27;133;251;6324;787;246;2.59;47.55;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2013-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neurology (Q2)"
155;6400153120;Chinese Medicine;journal;17498546;0.972;Q2;42;127;153;7789;764;151;5.50;61.33;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2020;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
156;29311;Current Cancer Drug Targets;journal;15680096, 18735576;0.972;Q1;91;75;234;5949;718;220;3.07;79.32;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2020;"Drug Discovery (Q1); Oncology (Q2); Pharmacology (Q2); Cancer Research (Q3)"
157;19700175230;Drug Design, Development and Therapy;journal;11778881;0.964;Q1;64;465;1081;20605;4507;1067;3.84;44.31;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2020;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
158;21100469670;Antibiotics;journal;20796382;0.960;Q1;35;926;415;54170;1892;407;4.36;58.50;Switzerland;Western Europe;MDPI Multidisciplinary Digital Publishing Institute;2010, 2012-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2); Infectious Diseases (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (medical) (Q2)"
159;21100829975;Clinical and Experimental Vaccine Research;journal;2287366X, 22873651;0.958;Q2;11;24;57;599;154;55;1.89;24.96;South Korea;Asiatic Region;Korean Vaccine Society;2017-2020;"Public Health, Environmental and Occupational Health (Q1); Immunology and Allergy (Q2); Infectious Diseases (Q2); Pharmacology (Q2)"
160;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.951;Q1;172;770;2060;43269;9232;2028;4.40;56.19;United Kingdom;Western Europe;Elsevier Ltd.;1982-2020;"Food Science (Q1); Toxicology (Q1); Medicine (miscellaneous) (Q2)"
161;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.947;Q2;97;47;168;3313;579;158;3.47;70.49;United States;Northern America;Elsevier Inc.;1987-2020;"Developmental Neuroscience (Q2); Toxicology (Q2); Cellular and Molecular Neuroscience (Q3)"
162;22411;Inflammopharmacology;journal;09254692, 15685608;0.945;Q2;50;122;304;7731;1308;303;4.07;63.37;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2020;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
163;24652;Chemico-Biological Interactions;journal;00092797;0.943;Q2;120;282;961;15415;4486;950;4.79;54.66;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2020;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
164;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.935;Q1;46;162;1223;4956;6274;1221;5.24;30.59;United States;Northern America;Informa Healthcare;2013-2020;"Biotechnology (Q1); Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2)"
165;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;0.935;Q2;43;8;53;17;133;49;2.46;2.13;United States;Northern America;International Antiviral Society;2011-2020;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Virology (Q3)"
166;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;0.934;Q1;174;383;1047;47182;4083;959;3.68;123.19;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2020;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
167;21100804457;Current Opinion in Toxicology;journal;24682020;0.932;Q2;21;58;200;2807;697;186;4.05;48.40;Netherlands;Western Europe;Elsevier BV;2016-2020;Toxicology (Q2)
168;29712;Clinical Therapeutics;journal;1879114X, 01492918;0.925;Q2;134;223;672;9030;1766;587;2.33;40.49;United States;Northern America;Elsevier Inc.;1977-2020;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
169;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.924;Q2;82;175;583;9832;2709;581;4.62;56.18;Netherlands;Western Europe;Elsevier;1996-2020;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
170;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;0.923;Q2;86;65;288;5920;1063;267;3.93;91.08;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)"
171;18071;Neurotoxicity Research;journal;14763524, 10298428;0.923;Q2;73;185;414;10854;1469;414;3.54;58.67;United States;Northern America;Springer New York;1999, 2001-2020;"Toxicology (Q2); Neuroscience (miscellaneous) (Q3)"
172;21100225613;Human gene therapy methods;journal;19466536, 19466544;0.920;Q2;27;0;80;0;232;80;2.14;0.00;United States;Northern America;Mary Ann Liebert Inc.;2012-2019;"Applied Microbiology and Biotechnology (Q2); Genetics (Q2); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (clinical) (Q3)"
173;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.920;Q2;116;201;553;7730;1452;522;2.61;38.46;United States;Northern America;Wiley-Blackwell;1973-2020;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
174;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.919;Q1;51;15;35;711;136;32;4.80;47.40;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2020;"Drug Discovery (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
175;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.916;Q2;75;185;471;9396;2414;471;4.77;50.79;United Kingdom;Western Europe;Informa Healthcare;1985-2020;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
176;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.907;Q2;75;0;13;0;39;12;0.00;0.00;United States;Northern America;SAGE Publications Inc.;1996-2017;"Analytical Chemistry (Q1); Biochemistry (Q2); Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
177;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.893;Q2;26;11;44;290;109;44;2.57;26.36;United States;Northern America;John Wiley and Sons Inc.;2001-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
178;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.890;Q1;90;122;284;9268;1309;276;4.66;75.97;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2020;Pharmaceutical Science (Q1)
179;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.890;Q2;107;218;755;9628;2516;684;2.89;44.17;United States;Northern America;Academic Press Inc.;1970, 1981-2020;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
180;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0.889;Q1;25;15;32;872;166;30;4.27;58.13;United States;Northern America;Springer Science + Business Media;2010-2020;"Pharmaceutical Science (Q1); Physical and Theoretical Chemistry (Q1); Biomedical Engineering (Q2); Oncology (Q2)"
181;19034;Microbial Drug Resistance;journal;10766294, 19318448;0.889;Q2;70;185;528;8151;1655;524;3.22;44.06;United States;Northern America;Mary Ann Liebert Inc.;1995-2020;"Medicine (miscellaneous) (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Immunology (Q3)"
182;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;0.885;Q2;192;848;1576;52041;6927;1567;4.27;61.37;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
183;19700175819;Patient Preference and Adherence;journal;1177889X;0.885;Q1;48;232;681;9520;1934;672;2.54;41.03;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2020;"Health Policy (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Medicine (miscellaneous) (Q2)"
184;21264;Drugs in R and D;journal;11796901, 11745886;0.873;Q2;45;37;131;1464;389;127;2.48;39.57;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2020;Pharmacology (Q2)
185;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.873;Q2;78;250;647;18475;1858;568;2.81;73.90;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
186;21100197929;Toxicological Research;journal;19768257, 22342753;0.872;Q2;30;47;122;1751;426;122;3.43;37.26;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2020;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
187;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.855;Q2;87;96;345;7331;1290;343;4.28;76.36;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2020;"Organic Chemistry (Q1); Drug Discovery (Q2); Molecular Medicine (Q2)"
188;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;0.853;Q2;43;476;391;21445;1234;382;2.91;45.05;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2020;"Internal Medicine (Q2); Pharmacology (Q2)"
189;144790;Marine Drugs;journal;16603397;0.848;Q2;110;676;1625;34488;7937;1620;4.76;51.02;Switzerland;Western Europe;MDPI Multidisciplinary Digital Publishing Institute;2004-2020;Drug Discovery (Q2)
190;21100811517;Birth Defects Research;journal;24721727;0.845;Q2;17;148;416;8693;917;375;1.89;58.74;United Kingdom;Western Europe;John Wiley and Sons Ltd;2017-2020;"Pediatrics, Perinatology and Child Health (Q1); Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
191;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.845;Q2;108;226;609;7489;1487;520;2.21;33.14;Germany;Western Europe;Springer Verlag;1968-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
192;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.845;Q2;28;70;88;3488;329;87;3.88;49.83;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2020;"Molecular Medicine (Q2); Pharmacology (Q2)"
193;24028;Reproductive Toxicology;journal;08906238, 18731708;0.845;Q2;112;217;456;9610;1563;438;2.89;44.29;United States;Northern America;Elsevier Inc.;1987-2020;Toxicology (Q2)
194;17700156705;Modern Trends in Pharmacopsychiatry;journal;16622685, 16624505;0.844;Q2;14;0;13;0;29;12;0.00;0.00;Switzerland;Western Europe;S. Karger AG;2009-2010, 2013, 2015, 2017;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
195;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.842;Q2;61;67;126;3777;563;102;5.04;56.37;Netherlands;Western Europe;Springer Netherlands;1984-2020;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
196;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.840;Q2;96;264;487;5719;1105;333;2.31;21.66;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2020;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
197;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;0.840;Q1;136;371;1337;20251;5912;1326;4.23;54.58;Netherlands;Western Europe;Elsevier;1993-2020;Pharmaceutical Science (Q1)
198;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.839;Q2;77;84;271;3559;775;271;2.75;42.37;Poland;Eastern Europe;Polish Physiological Society;1991-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q2)"
199;25171;Mycotoxin Research;journal;18671632, 01787888;0.839;Q2;36;42;106;2092;468;106;3.61;49.81;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2020;"Biotechnology (Q2); Toxicology (Q2); Microbiology (Q3)"
200;25224;Toxicology in Vitro;journal;18793177, 08872333;0.834;Q2;107;270;792;13018;2710;780;3.18;48.21;United Kingdom;Western Europe;Elsevier Ltd.;1987-2020;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
201;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.829;Q2;36;35;78;1600;343;77;4.60;45.71;Egypt;Africa/Middle East;Hindawi Limited;2010-2020;"Pharmacology (Q2); Toxicology (Q2)"
202;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.827;Q2;109;139;339;6394;1023;336;2.85;46.00;United States;Northern America;Springer New York;1973-2020;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
203;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.827;Q2;60;50;162;2315;343;157;2.07;46.30;United States;Northern America;Springer New York;1996-1999, 2001-2020;Pharmacology (Q2)
204;20664;Current Drug Targets;journal;18735592, 13894501;0.826;Q2;102;141;448;15650;1463;422;3.03;110.99;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2020;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
205;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.822;Q1;32;0;52;0;252;51;4.81;0.00;United States;Northern America;Hindawi Publishing Corporation;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
206;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;0.818;Q2;46;61;160;3026;404;151;2.40;49.61;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2020;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
207;4400151608;ChemMedChem;journal;18607187, 18607179;0.817;Q1;100;280;694;14637;2249;684;3.20;52.28;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
208;21123;Pharmaceutical Research;journal;07248741, 1573904X;0.815;Q1;206;242;666;11461;2637;650;3.78;47.36;United States;Northern America;Springer New York;1984-2020;"Pharmaceutical Science (Q1); Biotechnology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
209;25093;Environmental Toxicology;journal;15227278, 15204081;0.813;Q2;77;138;474;6171;1678;472;3.78;44.72;United States;Northern America;John Wiley and Sons Inc.;1980, 1999-2020;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
210;19700170617;EXCLI Journal;journal;16112156;0.812;Q2;37;148;318;6772;1078;258;3.13;45.76;Germany;Western Europe;Leibniz Research Centre for Working Environment and Human Factors;2009-2020;"Animal Science and Zoology (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
211;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;0.810;Q2;73;61;164;4398;490;163;2.89;72.10;United States;Northern America;Elsevier Inc.;1996, 1998-2020;"Biochemistry (Q2); Pharmacology (Q2); Physiology (Q2); Cell Biology (Q3)"
212;23155;Current Vascular Pharmacology;journal;15701611, 18756212;0.806;Q2;60;76;227;5973;609;198;2.08;78.59;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2020;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
213;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.805;Q2;90;140;516;5866;1426;491;2.96;41.90;United States;Northern America;Wiley-Blackwell;2004-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
214;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;0.804;Q2;85;89;233;4066;729;227;3.09;45.69;United Kingdom;Western Europe;Nature Publishing Group;2001-2020;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
215;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.803;Q2;58;1022;1334;48164;6831;1333;5.04;47.13;United States;Northern America;Academic Press Inc.;1971-2020;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
216;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.796;Q1;63;212;621;4823;1043;490;1.30;22.75;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2020;"Education (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacy (Q1); Medicine (miscellaneous) (Q2)"
217;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.787;Q2;50;66;188;2847;466;178;2.06;43.14;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2020;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
218;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.786;Q1;32;65;167;3673;741;166;4.47;56.51;China;Asiatic Region;Xi'an Jiaotong University;2011-2020;"Pharmaceutical Science (Q1); Pharmacy (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Electrochemistry (Q2); Spectroscopy (Q2)"
219;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.784;Q2;87;167;429;9553;1485;428;3.28;57.20;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2020;Toxicology (Q2)
220;21100830708;Toxics;journal;23056304;0.783;Q2;25;124;172;7756;718;166;3.79;62.55;Switzerland;Western Europe;MDPI AG;2013-2020;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
221;26370;Molecules;journal;14203049;0.782;Q1;149;6268;10353;302314;43650;10301;4.15;48.23;Switzerland;Western Europe;MDPI Multidisciplinary Digital Publishing Institute;1992, 1996-2020;"Chemistry (miscellaneous) (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
222;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;0.777;Q1;127;687;1950;23894;6995;1943;3.78;34.78;Netherlands;Western Europe;Elsevier;1983-2020;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Spectroscopy (Q2)"
223;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;0.776;Q1;177;404;1191;18698;4166;1128;3.43;46.28;United States;Northern America;John Wiley and Sons Inc.;1961-2020;Pharmaceutical Science (Q1)
224;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.773;Q1;35;80;239;4247;995;233;3.48;53.09;Iran;Middle East;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-2020;"Pharmaceutical Science (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
225;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.771;Q1;22;26;56;986;194;55;3.25;37.92;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmaceutical Science (Q1); Pharmacology (nursing) (Q1); Physical Therapy, Sports Therapy and Rehabilitation (Q2); Public Health, Environmental and Occupational Health (Q2); Sports Science (Q2)"
226;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.762;Q2;100;156;324;931;787;298;2.35;5.97;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2020;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
227;21100824046;Computational Toxicology;journal;24681113;0.754;Q2;12;26;106;1301;300;104;2.48;50.04;Netherlands;Western Europe;Elsevier BV;2017-2020;"Computer Science Applications (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
228;21100977423;RSC Medicinal Chemistry;journal;26328682;0.754;Q1;55;103;622;6155;2102;615;3.35;59.76;United Kingdom;Western Europe;Royal Society of Chemistry;2020;"Pharmaceutical Science (Q1); Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
229;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.753;Q2;108;147;359;8813;1170;358;3.22;59.95;United States;Northern America;Elsevier Inc.;1989, 2000-2021;"Animal Science and Zoology (Q1); Aquatic Science (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Cell Biology (Q3); Physiology (Q3)"
230;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.752;Q2;103;213;455;9503;1149;421;2.31;44.62;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2020;"Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
231;24785;Alcohol;journal;07418329;0.750;Q2;81;112;272;5532;645;266;2.06;49.39;United States;Northern America;Elsevier Inc.;1984-2020;"Biochemistry (Q2); Health (social science) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3); Neurology (Q3)"
232;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.749;Q2;101;103;265;6016;914;254;3.55;58.41;Netherlands;Western Europe;Springer Netherlands;1987-2020;"Computer Science Applications (Q2); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
233;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.747;Q2;99;88;303;3195;646;273;2.13;36.31;United Kingdom;Western Europe;Oxford University Press;1965-2020;"Medicine (miscellaneous) (Q2); Psychiatry and Mental Health (Q2); Toxicology (Q2)"
234;21790;Antiviral Therapy;journal;20402058, 13596535;0.747;Q2;87;8;252;297;464;243;2.00;37.13;United Kingdom;Western Europe;International Medical Press Ltd;1996-2019;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
235;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.745;Q1;68;73;140;2674;372;130;2.91;36.63;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2020;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
236;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;0.745;Q1;25;50;159;3366;711;158;5.24;67.32;Netherlands;Western Europe;Springer Netherlands;2012-2020;"Pharmaceutical Science (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
237;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.745;Q1;118;169;500;8431;1675;494;3.39;49.89;United States;Northern America;Wiley-Blackwell;1949-2020;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
238;21100238633;BioImpacts;journal;22285652, 22285660;0.743;Q1;32;35;94;1323;374;91;3.42;37.80;Iran;Middle East;Tabriz University of Medical Sciences;2011-2020;"Pharmaceutical Science (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
239;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.741;Q2;27;40;122;1498;396;122;3.15;37.45;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2020;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
240;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.740;Q2;82;53;190;2972;351;185;1.94;56.08;United States;Northern America;Wiley-Blackwell;1918-2020;"Inorganic Chemistry (Q1); Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3)"
241;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.732;Q2;37;193;323;12977;1234;316;4.07;67.24;United States;Northern America;Springer Publishing Company;2011-2020;Pharmaceutical Science (Q2)
242;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;0.730;Q2;72;18;43;2951;189;43;4.74;163.94;United States;Northern America;Begell House Inc.;1984-2020;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
243;21100444313;Sustainable Chemistry and Pharmacy;journal;23525541;0.728;Q2;19;145;155;7946;722;151;4.57;54.80;Netherlands;Western Europe;Elsevier BV;2015-2020;"Environmental Chemistry (Q2); Management, Monitoring, Policy and Law (Q2); Pharmaceutical Science (Q2); Pollution (Q2)"
244;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.727;Q2;61;98;279;3626;583;254;2.13;37.00;United States;Northern America;Mary Ann Liebert Inc.;1992, 1995-2020;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
245;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.724;Q2;53;70;194;2479;584;120;3.03;35.41;Italy;Western Europe;SAGE Publications Inc.;1989-2020;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
246;21100896684;International Journal of Pharmaceutics: X;journal;25901567;0.724;Q2;6;21;36;867;130;36;3.61;41.29;Netherlands;Western Europe;Elsevier BV;2019-2020;Pharmaceutical Science (Q2)
247;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.723;Q2;52;60;175;2591;511;175;2.79;43.18;United States;Northern America;Humana Press;2001-2020;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
248;18966;Mutagenesis;journal;02678357, 14643804;0.723;Q2;91;47;141;2973;484;138;2.66;63.26;United Kingdom;Western Europe;Oxford University Press;1986-2020;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
249;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.721;Q2;161;423;1756;19482;5844;1743;3.41;46.06;United Kingdom;Western Europe;Elsevier Ltd.;1993-2020;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
250;25075;Ecotoxicology;journal;09639292, 15733017;0.720;Q2;90;187;374;11596;1046;371;2.65;62.01;Netherlands;Western Europe;Springer Netherlands;1992-2020;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
251;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.719;Q1;55;127;607;5947;1443;600;2.28;46.83;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2020;"Chemical Health and Safety (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
252;19600166302;Current Molecular Pharmacology;journal;18744702;0.717;Q2;39;32;89;2336;243;82;3.00;73.00;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2020;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
253;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.716;Q2;59;91;193;3294;533;187;2.65;36.20;United States;Northern America;Mary Ann Liebert Inc.;1996-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3)"
254;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;0.715;Q2;16;116;127;3174;162;117;1.22;27.36;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2020;"Pharmaceutical Science (Q2); Statistics and Probability (Q2)"
255;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.714;Q2;89;59;331;3459;823;321;2.30;58.63;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2020;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
256;20049;Behavioural Pharmacology;journal;14735849, 09558810;0.711;Q2;80;77;224;4341;518;216;2.22;56.38;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2020;"Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
257;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;0.711;Q2;22;130;276;3254;551;260;1.99;25.03;United States;Northern America;Wiley-Blackwell;2012-2020;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2)"
258;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.710;Q2;42;26;92;2460;301;88;3.63;94.62;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Oncology (Q3)"
259;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.710;Q2;47;306;514;12998;1395;404;2.57;42.48;United States;Northern America;Elsevier Inc.;2005-2020;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
260;21100241601;Toxicology Research;journal;2045452X, 20454538;0.709;Q2;31;67;301;3408;966;298;3.23;50.87;United Kingdom;Western Europe;Royal Society of Chemistry;2012-2020;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
261;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;0.708;Q2;69;160;591;9189;1802;539;2.84;57.43;United Kingdom;Western Europe;Future Science;2009-2020;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
262;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;0.706;Q2;116;241;739;21813;2255;624;2.62;90.51;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2020;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
263;130063;Pharmacological Reports;journal;17341140;0.706;Q2;83;156;526;8507;1574;524;2.71;54.53;Netherlands;Western Europe;Elsevier BV;2005-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
264;22205;Saudi Pharmaceutical Journal;journal;13190164;0.706;Q2;49;217;484;10105;2146;484;4.45;46.57;Saudi Arabia;Middle East;King Saud University;1996-2020;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
265;21100241624;International Journal of Genomics;journal;2314436X, 23144378;0.705;Q2;24;62;219;3036;554;214;2.19;48.97;Egypt;Africa/Middle East;Hindawi Limited;2013-2020;"Pharmaceutical Science (Q2); Biochemistry (Q3); Genetics (Q3); Molecular Biology (Q3)"
266;22072;Current Gene Therapy;journal;18755631, 15665232;0.704;Q2;71;38;130;2994;379;114;3.05;78.79;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2020;"Drug Discovery (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
267;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.703;Q2;74;30;118;1476;363;114;3.11;49.20;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2020;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
268;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.702;Q2;64;148;469;5837;1742;468;3.46;39.44;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2020;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
269;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.701;Q2;49;70;188;3465;495;184;2.38;49.50;United Kingdom;Western Europe;Informa Healthcare;1978-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
270;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.693;Q2;89;151;440;7134;1004;430;2.20;47.25;United States;Northern America;Springer New York;1973-2020;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Environmental Science (miscellaneous) (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
271;20682;Current Pharmaceutical Design;journal;13816128, 18734286;0.690;Q2;159;515;1637;53205;4737;1517;2.63;103.31;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2020;"Drug Discovery (Q2); Pharmacology (Q2)"
272;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.689;Q2;91;120;158;4072;425;154;3.00;33.93;United States;Northern America;John Wiley and Sons Ltd;1998-2020;"Drug Discovery (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
273;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.685;Q1;29;60;175;2018;551;175;3.13;33.63;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
274;21100446418;Contemporary Clinical Trials Communications;journal;24518654;0.678;Q2;14;182;398;6776;680;391;1.77;37.23;United States;Northern America;Elsevier Inc.;2015-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
275;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.678;Q2;68;41;124;1303;291;117;2.08;31.78;United States;Northern America;Mary Ann Liebert Inc.;2008-2020;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
276;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.672;Q3;36;21;62;1007;180;62;2.83;47.95;United States;Northern America;Informa Healthcare;2004-2020;"Immunology (Q3); Toxicology (Q3)"
277;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.670;Q2;91;236;393;11227;963;376;2.62;47.57;Germany;Western Europe;Springer Verlag;1969-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
278;20663;Current Drug Metabolism;journal;18755453, 13892002;0.667;Q2;106;115;342;8505;1134;309;3.37;73.96;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2020;"Pharmacology (Q2); Clinical Biochemistry (Q3)"
279;59665;Chinese Journal of Natural Medicines;journal;16723651;0.664;Q2;35;107;318;4850;915;313;2.88;45.33;China;Asiatic Region;China Pharmaceutical University;2004-2020;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
280;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.663;Q2;44;658;1051;39436;4060;1050;3.92;59.93;France;Western Europe;Editions de Sante;2004-2020;Pharmaceutical Science (Q2)
281;21100862294;Neuropsychopharmacology Reports;journal;2574173X;0.661;Q2;13;61;69;1641;124;68;1.80;26.90;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2020;"Clinical Psychology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
282;25109;Inhalation Toxicology;journal;08958378, 10917691;0.660;Q3;87;49;172;2408;397;162;2.27;49.14;United Kingdom;Western Europe;Informa Healthcare;1989-2020;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
283;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.655;Q2;73;101;222;4352;560;205;2.19;43.09;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2020;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
284;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.653;Q2;64;295;534;7768;1022;446;1.45;26.33;United States;Northern America;American Pharmacists Association;2003-2020;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q2)"
285;19374;AAPS PharmSciTech;journal;15309932;0.652;Q2;93;314;1028;15122;3328;1016;3.25;48.16;Switzerland;Western Europe;Springer International Publishing AG;2000-2020;"Agronomy and Crop Science (Q2); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
286;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.652;Q2;44;156;421;7074;946;394;2.12;45.35;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2020;"Drug Discovery (Q2); Biochemistry (medical) (Q3); Clinical Biochemistry (Q3)"
287;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.651;Q2;93;159;377;4447;878;376;2.12;27.97;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2020;"Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Oncology (Q3)"
288;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.649;Q2;93;130;303;1266;737;284;2.52;9.74;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2020;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
289;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.645;Q2;42;70;121;3671;366;117;2.69;52.44;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2020;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
290;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.644;Q1;18;70;102;2405;214;94;2.27;34.36;United Kingdom;Western Europe;BioMed Central Ltd.;2013-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacy (Q1); Health Policy (Q2)"
291;16067;Reading Teacher;journal;00340561;0.642;Q2;50;94;297;2131;285;258;0.89;22.67;United States;Northern America;Wiley-Blackwell;1995-2020;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
292;21100932732;PharmacoEconomics - Open;journal;25094262, 25094254;0.637;Q2;10;53;135;2001;252;120;1.77;37.75;Switzerland;Western Europe;Springer Nature Switzerland AG;2017-2019;"Health Policy (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
293;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.635;Q2;117;286;882;10145;2009;871;2.15;35.47;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2020;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
294;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.634;Q3;75;182;597;7155;1690;594;2.84;39.31;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2020;"Chemistry (miscellaneous) (Q2); Food Science (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
295;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.633;Q1;19;198;567;4543;823;518;1.39;22.94;United States;Northern America;Elsevier Inc.;2009-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacy (Q1)"
296;21100924771;Natural Products and Bioprospecting;journal;21922209, 21922195;0.633;Q3;21;46;111;2240;375;111;2.90;48.70;Singapore;Asiatic Region;Springer Singapore;2011-2020;"Analytical Chemistry (Q2); Food Science (Q2); Organic Chemistry (Q2); Plant Science (Q2); Biochemistry (Q3); Pharmacology (Q3); Toxicology (Q3)"
297;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.628;Q2;86;200;615;9321;1966;614;3.04;46.61;United States;Northern America;Informa Healthcare;1974, 1976-2020;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
298;18077;Fitoterapia;journal;0367326X, 18736971;0.624;Q2;103;270;798;11168;2270;798;2.77;41.36;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2020;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
299;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.624;Q1;56;95;316;4937;805;268;2.46;51.97;China;Asiatic Region;Zhejiang University Press;2005-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Veterinary (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
300;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.622;Q3;73;228;412;7304;902;377;2.14;32.04;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2020;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
301;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.620;Q2;63;75;242;2866;949;230;3.69;38.21;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2020;"Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2)"
302;130031;Journal of Toxicologic Pathology;journal;09149198;0.619;Q3;27;36;120;990;216;120;1.63;27.50;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2020;"Pathology and Forensic Medicine (Q2); Toxicology (Q3)"
303;19700200821;Therapeutic Delivery;journal;20415990, 20416008;0.619;Q2;46;66;251;3504;684;226;2.45;53.09;United Kingdom;Western Europe;Future Science;2010-2020;Pharmaceutical Science (Q2)
304;21100218055;"BMC pharmacology &amp; toxicology";journal;20506511;0.618;Q3;30;88;258;3326;657;258;2.44;37.80;United Kingdom;Western Europe;BioMed Central Ltd.;2012-2020;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
305;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.617;Q2;147;657;2293;20184;6212;2292;2.65;30.72;United Kingdom;Western Europe;Elsevier Ltd.;1991-2020;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
306;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.613;Q2;88;147;487;5061;1208;487;2.38;34.43;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2020;"Biophysics (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q3); Cell Biology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Immunology (Q4)"
307;25214;Toxicologic Pathology;journal;15331601, 01926233;0.613;Q3;108;103;296;5006;528;283;1.72;48.60;United States;Northern America;SAGE Publications Inc.;1972-2020;"Pathology and Forensic Medicine (Q2); Cell Biology (Q3); Molecular Biology (Q3); Toxicology (Q3)"
308;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.611;Q2;39;222;565;11024;1564;559;2.66;49.66;Iran;Middle East;Mashhad University of Medical Sciences;2007-2020;"Biophysics (Q2); Drug Discovery (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
309;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.608;Q2;24;82;170;3164;396;164;1.95;38.59;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2020;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
310;21100455212;Biomedical Reports;journal;20499434, 20499442;0.607;Q2;25;139;363;5986;712;363;1.94;43.06;Greece;Western Europe;Spandidos Publications;2014-2020;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
311;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;0.603;Q2;89;149;352;14217;1221;338;3.52;95.42;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2020;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3); Pharmacology (Q3); Cancer Research (Q4)"
312;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.601;Q3;39;38;100;1588;250;100;2.39;41.79;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2020;"Safety Research (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
313;20634;Journal of Texture Studies;journal;00224901, 17454603;0.593;Q2;54;97;201;4175;510;189;2.71;43.04;United States;Northern America;Wiley-Blackwell;1969-2020;"Food Science (Q2); Pharmaceutical Science (Q2)"
314;4000150314;Chemical Biology and Drug Design;journal;17470277;0.590;Q2;77;123;599;5744;1541;537;2.57;46.70;United Kingdom;Western Europe;Blackwell;2006-2020;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
315;19700175244;Current Radiopharmaceuticals;journal;18744710, 18744729;0.586;Q3;25;23;93;922;211;85;2.83;40.09;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Radiology, Nuclear Medicine and Imaging (Q2); Pharmacology (Q3)"
316;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.585;Q3;46;32;88;1692;267;88;3.33;52.88;United States;Northern America;Begell House Inc.;1984-1990, 1992-2020;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q3)"
317;21192;Drug Development Research;journal;02724391, 10982299;0.582;Q2;60;145;190;7895;567;181;3.23;54.45;United States;Northern America;John Wiley and Sons Inc.;1981-2020;Drug Discovery (Q2)
318;26512;Tetrahedron;journal;14645416, 00404020;0.581;Q2;221;465;2362;26230;5335;2349;2.31;56.41;United Kingdom;Western Europe;Elsevier Ltd.;1957-2020;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3)"
319;23039;Journal of Liposome Research;journal;08982104, 15322394;0.579;Q2;51;59;107;3170;339;105;3.29;53.73;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2020;Pharmaceutical Science (Q2)
320;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;0.579;Q2;140;30;134;1138;336;123;1.55;37.93;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Genetics (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Genetics (clinical) (Q4)"
321;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;0.578;Q3;30;20;74;945;188;73;2.18;47.25;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2020;"Chemical Health and Safety (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
322;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.576;Q2;26;13;47;1511;136;45;3.24;116.23;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3)"
323;16533;Phytochemical Analysis;journal;09580344, 10991565;0.574;Q2;72;112;201;4284;594;198;3.01;38.25;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2020;"Complementary and Alternative Medicine (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Food Science (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
324;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.573;Q3;37;73;247;2702;551;239;2.19;37.01;France;Western Europe;Springer Paris;1976-2020;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
325;25106;Human and Experimental Toxicology;journal;09603271;0.572;Q3;78;181;383;8831;1100;374;3.01;48.79;United States;Northern America;SAGE Publications Inc.;1981-2020;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
326;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.569;Q2;44;188;400;2194;437;339;1.12;11.67;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2020;"Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2)"
327;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.569;Q3;35;46;126;2739;349;124;3.11;59.54;Netherlands;Western Europe;Wageningen Academic Publishers;2009-2020;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
328;19700188217;Bioanalysis;journal;17576180, 17576199;0.566;Q2;58;163;593;4671;986;515;1.65;28.66;United Kingdom;Western Europe;Future Science;2009-2020;"Analytical Chemistry (Q2); Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Clinical Biochemistry (Q3)"
329;5800173383;Current Clinical Pharmacology;journal;15748847;0.565;Q2;41;28;95;1263;199;89;2.30;45.11;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
330;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.563;Q3;50;70;234;2599;489;191;2.15;37.13;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2020;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
331;22319;Toxicon;journal;18793150, 00410101;0.561;Q3;128;483;719;13087;1868;703;2.73;27.10;United Kingdom;Western Europe;Elsevier Ltd.;1962-2020;Toxicology (Q3)
332;15840;Journal of Antibiotics;journal;00218820, 18811469;0.560;Q3;80;125;468;4013;1261;438;2.31;32.10;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2020;"Drug Discovery (Q3); Pharmacology (Q3)"
333;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.559;Q3;84;113;498;4879;1068;490;2.01;43.18;Canada;Northern America;National Research Council of Canada;1964-2020;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q3); Physiology (medical) (Q3)"
334;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;0.558;Q2;75;80;542;72;1474;538;2.96;0.90;United States;Northern America;American Scientific Publishers;2007-2020;"Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Medicine (miscellaneous) (Q3)"
335;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.557;Q3;50;93;258;2448;223;246;0.91;26.32;United States;Northern America;Taylor and Francis Ltd.;1991-2020;"Pharmacology (Q3); Pharmacology (medical) (Q3); Statistics and Probability (Q3)"
336;21100366771;Journal of Applied Research on Medicinal and Aromatic Plants;journal;22147861;0.556;Q3;20;41;141;2008;462;138;3.48;48.98;Germany;Western Europe;Elsevier GmbH;2014-2020;"Plant Science (Q2); Drug Discovery (Q3)"
337;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;0.555;Q2;85;163;379;9603;899;355;2.46;58.91;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2020;"Biotechnology (Q2); Pharmaceutical Science (Q2)"
338;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.555;Q3;12;55;34;3286;113;34;2.24;59.75;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010, 2012-2020;"Molecular Medicine (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
339;21100239265;PharmaNutrition;journal;22134344;0.548;Q3;20;58;68;4254;236;68;2.18;73.34;Netherlands;Western Europe;Elsevier BV;2013-2020;"Food Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
340;21100815317;Journal of Pharmacopuncture;journal;20936966, 22346856;0.546;Q3;13;23;104;784;238;103;1.64;34.09;South Korea;Asiatic Region;Korean Pharmacopuncture Institute;2016-2020;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
341;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.545;Q3;66;0;83;0;219;83;0.00;0.00;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Pathology and Forensic Medicine (Q2); Medicine (miscellaneous) (Q3); Toxicology (Q3); Cell Biology (Q4)"
342;27210;In Vivo;journal;17917549, 0258851X;0.545;Q3;60;486;722;14812;1566;722;2.09;30.48;Greece;Western Europe;International Institute of Anticancer Research;1987-2020;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
343;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.543;Q3;70;281;779;10149;1636;768;2.11;36.12;United States;Northern America;Springer New York;1966-2020;"Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q3)"
344;24578;Mathematical Medicine and Biology;journal;14778599;0.542;Q3;45;22;72;1002;135;72;2.13;45.55;United Kingdom;Western Europe;Oxford University Press;1984-2020;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Modeling and Simulation (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
345;21100854647;Applied In Vitro Toxicology;journal;23321512, 23321539;0.541;Q3;9;14;61;491;129;54;2.11;35.07;United States;Northern America;Mary Ann Liebert Inc.;2015-2020;"Medical Laboratory Technology (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
346;21167;Pharmacogenomics;journal;14622416, 17448042;0.541;Q3;91;120;424;5591;835;405;1.80;46.59;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2020;"Genetics (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
347;26514;Tetrahedron Letters;journal;00404039, 18733581;0.541;Q3;168;792;2806;30603;6014;2806;2.25;38.64;United Kingdom;Western Europe;Elsevier Ltd.;1959-2020;"Organic Chemistry (Q2); Biochemistry (Q3); Drug Discovery (Q3)"
348;20570;Chemotherapy;journal;00093157, 14219794;0.539;Q3;54;29;116;882;227;109;2.17;30.41;Switzerland;Western Europe;S. Karger AG;1960-2020;"Drug Discovery (Q3); Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
349;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.538;Q2;59;234;523;7097;976;489;1.76;30.33;Netherlands;Western Europe;Springer Netherlands;2011-2020;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q3)"
350;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.534;Q3;49;70;144;1630;290;116;1.55;23.29;United States;Northern America;Springer New York;2005-2020;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
351;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.532;Q2;62;83;219;2979;523;215;2.67;35.89;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2020;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3); Drug Discovery (Q3)"
352;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.530;Q3;24;32;37;992;70;37;1.42;31.00;New Zealand;Pacific Region;Dove Medical Press Limited;2009-2020;"Health Policy (Q2); Pharmacology (Q3)"
353;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.527;Q3;60;104;315;3865;448;311;1.41;37.16;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2020;"Veterinary (miscellaneous) (Q2); Pharmacology (Q3)"
354;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.526;Q3;58;181;419;8838;1437;413;3.60;48.83;United States;Northern America;John Wiley and Sons Inc.;1998-2020;"Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
355;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.517;Q2;78;52;189;2389;557;189;2.81;45.94;United Kingdom;Western Europe;Informa Healthcare;1984-2020;"Organic Chemistry (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2); Bioengineering (Q3); Colloid and Surface Chemistry (Q3)"
356;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.515;Q3;50;89;187;3205;309;181;1.51;36.01;United Kingdom;Western Europe;Maney Publishing;1989-2020;"Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
357;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.514;Q3;29;56;205;2231;368;204;1.78;39.84;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2020;"Pharmacology (Q3); Physiology (Q3)"
358;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.512;Q2;46;93;298;2431;667;278;2.21;26.14;Germany;Western Europe;Springer Verlag;2006-2020;"Complementary and Alternative Medicine (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
359;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.512;Q2;41;57;121;2933;423;121;3.43;51.46;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2020;Pharmaceutical Science (Q2)
360;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.512;Q3;57;101;249;3957;584;238;2.07;39.18;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2020;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
361;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.511;Q2;58;127;386;6090;994;369;2.49;47.95;United States;Northern America;Informa Healthcare;1996-2020;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3)"
362;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.510;Q3;30;47;109;2685;359;106;2.71;57.13;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2020;"Animal Science and Zoology (Q2); Infectious Diseases (Q3); Parasitology (Q3); Toxicology (Q3)"
363;21194;Pharmacology;journal;00317012, 14230313;0.510;Q3;59;84;244;3111;456;238;1.79;37.04;Switzerland;Western Europe;S. Karger AG;1959-2020;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
364;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.509;Q3;31;44;132;1867;185;118;1.44;42.43;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
365;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.508;Q3;96;232;593;14858;1422;577;2.27;64.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2018;"Molecular Medicine (Q3); Pharmacology (Q3); Cancer Research (Q4)"
366;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.507;Q3;47;394;753;19252;1857;747;2.53;48.86;United States;Northern America;Wiley-Blackwell;1977-2020;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
367;13671;Biologicals;journal;10958320, 10451056;0.503;Q3;56;76;238;2236;442;233;1.80;29.42;United States;Northern America;Academic Press Inc.;1990-2020;"Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
368;21100793213;Current Pharmacology Reports;journal;2198641X;0.503;Q3;21;40;123;3327;218;121;1.52;83.18;Switzerland;Western Europe;Springer International Publishing AG;2015-2020;"Biochemistry (Q3); Drug Discovery (Q3); Genetics (Q3); Pharmacology (Q3)"
369;19300156901;Dose-Response;journal;15593258;0.502;Q3;36;192;268;7831;662;228;2.28;40.79;United States;Northern America;International Dose-Response Society;2008-2020;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
370;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.497;Q2;78;38;150;1882;306;150;1.84;49.53;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2020;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
371;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.493;Q3;41;75;229;3854;609;227;2.84;51.39;United Kingdom;Western Europe;Informa Healthcare;1991-2020;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
372;4500151530;Personalized Medicine;journal;17410541;0.489;Q3;31;38;194;2033;311;159;1.46;53.50;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2020;"Medicine (miscellaneous) (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
373;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.487;Q3;96;359;1097;5280;1321;880;1.22;14.71;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2020;"Pharmacy (Q1); Health Policy (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
374;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.486;Q3;78;49;179;1149;280;165;1.31;23.45;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2020;"Neurology (clinical) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
375;21100853513;Pharmaceutical Nanotechnology;journal;22117385, 22117393;0.486;Q2;7;37;42;1838;114;37;2.69;49.68;Netherlands;Western Europe;Bentham Science Publishers B.V.;2014-2016, 2018-2020;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3)"
376;19900192900;Molecular Informatics;journal;18681751, 18681743;0.481;Q3;68;77;196;3339;536;185;3.02;43.36;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2020;"Computer Science Applications (Q2); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
377;25898;Journal of Peptide Science;journal;10752617, 10991387;0.475;Q3;66;47;242;1900;457;237;1.69;40.43;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2020;"Biochemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Biology (Q4); Structural Biology (Q4)"
378;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.471;Q3;30;110;307;3926;618;305;1.94;35.69;United States;Northern America;Begell House Inc.;2005-2020;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
379;14805;Steroids;journal;0039128X, 18785867;0.469;Q3;104;141;438;6408;1026;433;2.50;45.45;United States;Northern America;Elsevier Inc.;1963-2020;"Biochemistry (Q3); Clinical Biochemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Endocrinology (Q4); Molecular Biology (Q4)"
380;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.468;Q2;61;121;264;6497;817;261;3.43;53.69;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2020;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
381;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.468;Q3;70;243;314;13306;673;300;2.20;54.76;United States;Northern America;Wiley-Blackwell;1986-2020;"Process Chemistry and Technology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
382;145693;Canadian Pharmacists Journal;journal;17151635;0.468;Q2;21;71;192;1174;266;110;1.44;16.54;Canada;Northern America;Canadian Pharmacists Association;2005-2020;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
383;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.466;Q2;32;177;433;3097;464;244;0.87;17.50;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2020;"Anesthesiology and Pain Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
384;14822;Xenobiotica;journal;00498254, 13665928;0.465;Q3;81;164;416;6765;711;416;1.62;41.25;United Kingdom;Western Europe;Informa Healthcare;1971-2020;"Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Toxicology (Q3)"
385;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.450;Q3;48;49;166;2590;422;166;2.75;52.86;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2020;"Bioengineering (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
386;21100873055;Cosmetics;journal;20799284;0.449;Q2;21;94;182;4796;525;175;2.93;51.02;Switzerland;Western Europe;MDPI AG;2014-2020;"Chemical Engineering (miscellaneous) (Q2); Pharmaceutical Science (Q2); Dermatology (Q3); Surgery (Q3); Aging (Q4)"
387;130025;Current Drug Delivery;journal;15672018;0.449;Q2;62;76;319;5298;726;304;2.46;69.71;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2020;Pharmaceutical Science (Q2)
388;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.449;Q3;23;10;66;268;91;66;1.19;26.80;United States;Northern America;John Wiley and Sons Inc.;2001-2020;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
389;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.449;Q3;39;43;73;1512;141;65;1.47;35.16;United States;Northern America;Elsevier Inc.;1959-2020;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
390;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.448;Q3;32;36;116;1742;261;112;1.94;48.39;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2020;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
391;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.440;Q3;21;0;8;0;10;7;0.00;0.00;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
392;21100470510;Drug Research;journal;21949379, 21949387;0.433;Q3;63;92;328;2319;603;291;1.86;25.21;Germany;Western Europe;Thieme;1972, 2013-2020;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
393;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.432;Q3;58;64;184;2751;270;159;1.61;42.98;United States;Northern America;SAGE Publications Inc.;1982-2020;Toxicology (Q3)
394;23412;Journal of AOAC International;journal;10603271;0.432;Q3;87;97;763;2706;1078;737;1.43;27.90;United States;Northern America;AOAC International;1993-2020;"Agronomy and Crop Science (Q2); Food Science (Q2); Analytical Chemistry (Q3); Environmental Chemistry (Q3); Pharmacology (Q3)"
395;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.432;Q3;47;63;278;2037;396;269;1.55;32.33;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2020;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
396;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.432;Q2;46;77;321;2370;713;321;2.09;30.78;Brazil;Latin America;Springer Nature Switzerland AG;2007-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
397;16948;Chirality;journal;1520636X, 08990042;0.430;Q3;77;130;322;5093;696;316;2.25;39.18;United States;Northern America;Wiley-Liss Inc.;1989-2020;"Analytical Chemistry (Q3); Catalysis (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Spectroscopy (Q3)"
398;17500155003;Records of Natural Products;journal;13076167;0.430;Q3;31;49;215;1263;387;214;1.80;25.78;Turkey;Middle East;ACG Publications;2009-2021;"Plant Science (Q2); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
399;35190;Revista Espanola de Quimioterapia;journal;02143429;0.430;Q3;25;80;337;2051;324;232;0.99;25.64;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2020;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
400;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.422;Q3;12;0;112;0;162;107;1.57;0.00;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q2); Environmental Science (miscellaneous) (Q2); Toxicology (Q3)"
401;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.422;Q3;44;223;288;11770;598;285;2.10;52.78;United States;Northern America;Informa Healthcare;1977-2020;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
402;21744;Planta Medica;journal;14390221, 00320943;0.422;Q2;116;157;465;7078;1378;446;3.11;45.08;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2020;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
403;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.420;Q2;37;101;229;3120;312;195;1.35;30.89;United Kingdom;Western Europe;Wiley-Blackwell;1991-2020;"Pharmaceutical Science (Q2); Pharmacy (Q2); Health Policy (Q3); Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3)"
404;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.419;Q2;58;28;134;1438;238;131;1.67;51.36;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2020;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
405;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.418;Q3;52;60;164;2543;296;162;1.97;42.38;Spain;Western Europe;Prous Science;1968, 1978-2020;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
406;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.415;Q3;39;17;49;759;95;43;1.90;44.65;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
407;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.414;Q3;33;150;235;6236;404;228;1.65;41.57;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2020;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
408;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.413;Q2;38;58;166;163;133;145;0.78;2.81;United States;Northern America;Parenteral Drug Association Inc.;1994-2020;Pharmaceutical Science (Q2)
409;21100212330;Drug Discoveries and Therapeutics;journal;1881784X, 18817831;0.404;Q2;23;1;59;0;92;59;1.27;0.00;Japan;Asiatic Region;"International Advancement Center for Medicine &amp; Health Research Co., Ltd. (IACMHR Co., Ltd.)";1997, 2010-2018, 2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
410;21100896682;Toxicon: X;journal;25901710;0.404;Q4;5;44;17;2880;41;17;2.41;65.45;United Kingdom;Western Europe;Elsevier Ltd.;2019-2020;Toxicology (Q4)
411;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.403;Q3;17;47;103;1240;112;97;1.06;26.38;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2020;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
412;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.402;Q3;56;48;127;1257;160;115;1.31;26.19;United States;Northern America;Mary Ann Liebert Inc.;2002-2020;"Drug Discovery (Q3); Molecular Medicine (Q4)"
413;130089;Toxin Reviews;journal;15569543, 15569551;0.402;Q4;43;127;182;8122;467;178;2.27;63.95;United Kingdom;Western Europe;Informa Healthcare;1982-2020;Toxicology (Q4)
414;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.401;Q2;59;38;127;1268;274;127;2.28;33.37;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2021;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
415;23942;Biomedical Chromatography;journal;10990801, 02693879;0.400;Q3;65;278;841;8469;1410;836;1.66;30.46;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2020;"Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Biology (Q4)"
416;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.399;Q2;26;65;248;1777;404;233;1.57;27.34;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Clinical Psychology (Q3); Medicine (miscellaneous) (Q3); Immunology and Microbiology (miscellaneous)  (Q4)"
417;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;0.395;Q2;19;79;207;2841;265;197;1.16;35.96;United States;Northern America;Elsevier USA;2012-2020;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3)"
418;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.393;Q3;92;161;528;6152;839;515;1.61;38.21;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2020;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
419;21100860941;Expert Review of Precision Medicine and Drug Development;journal;23808993;0.387;Q3;11;43;115;4041;150;92;1.39;93.98;United Kingdom;Western Europe;Taylor and Francis Ltd.;2016-2020;"Drug Discovery (Q3); Pharmacology (Q3); Genetics (Q4); Molecular Medicine (Q4)"
420;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.385;Q3;23;16;162;462;196;135;0.80;28.88;Bangladesh;Asiatic Region;Bangladesh Pharmacological Society;2009-2020;Pharmacology (Q3)
421;29053;Molecular Diversity;journal;1573501X, 13811991;0.385;Q3;57;186;228;9704;522;227;2.51;52.17;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2020;"Information Systems (Q2); Catalysis (Q3); Drug Discovery (Q3); Inorganic Chemistry (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Molecular Biology (Q4)"
422;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.382;Q2;29;137;98;6019;186;96;2.02;43.93;United States;Northern America;Springer New York;2006-2020;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
423;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.375;Q3;25;135;172;4502;300;143;1.28;33.35;Netherlands;Western Europe;Wolters Kluwer Medknow Publications;2010-2020;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
424;19700175099;Topics in Medicinal Chemistry;book series;1862247X, 18622461;0.373;Q3;11;34;113;4308;69;6;0.63;126.71;Germany;Western Europe;Springer Verlag;2009-2012, 2014-2020;"Drug Discovery (Q3); Molecular Medicine (Q4)"
425;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.370;Q2;40;150;604;5786;1109;598;1.69;38.57;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2007-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
426;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.365;Q3;40;41;87;1604;127;82;1.47;39.12;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
427;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.363;Q3;67;101;297;2115;320;282;1.09;20.94;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2020;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
428;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.362;Q4;29;61;200;2071;329;197;1.67;33.95;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2020;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
429;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.361;Q4;62;116;146;4269;178;128;1.13;36.80;United States;Northern America;Heldref Publications;2005-2020;"Environmental Science (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
430;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.358;Q2;40;224;424;4352;626;393;1.41;19.43;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2020;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
431;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.353;Q3;71;69;416;2745;451;413;0.75;39.78;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2020;"Pharmacology (Q3); Toxicology (Q4)"
432;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.352;Q2;45;182;711;8210;1367;711;1.85;45.11;United States;Northern America;Birkhauser Boston;1994, 1996-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
433;21717;Die Pharmazie;journal;00317144;0.351;Q2;63;129;407;3107;562;407;1.17;24.09;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2020;Pharmaceutical Science (Q2)
434;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.349;Q3;62;134;537;1054;460;271;0.69;7.87;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2020;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
435;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.346;Q2;35;46;80;1757;127;75;1.75;38.20;Germany;Western Europe;Walter de Gruyter GmbH;2015-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
436;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.342;Q3;34;20;72;1241;113;66;1.73;62.05;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019;"Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
437;21100833039;Journal of HerbMed Pharmacology;journal;23455004;0.341;Q3;10;49;120;2315;214;119;2.09;47.24;Iran;Middle East;Nickan Research Institute;2015-2020;Drug Discovery (Q3)
438;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0.341;Q3;30;12;46;391;66;39;1.75;32.58;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2019;"Drug Discovery (Q3); Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
439;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.339;Q4;8;47;125;1413;84;114;0.53;30.06;France;Western Europe;Elsevier Masson SAS;2014-2020;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
440;5800173386;Current Drug Safety;journal;15748863;0.334;Q3;34;36;120;1064;150;118;1.36;29.56;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q4)"
441;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.325;Q3;33;40;99;888;199;89;1.79;22.20;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2020;Pharmaceutical Science (Q3)
442;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.322;Q3;54;123;116;4407;163;112;1.43;35.83;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
443;79053;Natural Product Sciences;journal;12263907;0.322;Q3;25;44;143;1563;224;143;1.71;35.52;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2020;"Drug Discovery (Q3); Organic Chemistry (Q3)"
444;130047;Current Drug Discovery Technologies;journal;15701638;0.319;Q3;43;70;105;4231;180;101;1.72;60.44;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2020;Drug Discovery (Q3)
445;19700180522;Molecular and Cellular Toxicology;journal;20928467, 1738642X;0.312;Q2;21;48;150;1705;195;150;1.01;35.52;Germany;Western Europe;Springer Verlag;2010-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
446;21100841779;ADMET and DMPK;journal;18487718;0.309;Q2;13;26;66;1467;91;61;1.32;56.42;Croatia;Eastern Europe;International Association of Physical Chemists;2013-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Health (social science) (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
447;22338;Hospital Pharmacy;journal;19451253, 00185787;0.309;Q3;22;158;289;3678;258;246;0.70;23.28;United States;Northern America;Thomas Land Publishers Inc.;1973-2020;"Pharmacy (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
448;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.308;Q3;44;92;246;4815;560;242;2.17;52.34;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2020;Drug Discovery (Q3)
449;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.306;Q2;30;17;118;632;195;118;1.85;37.18;Spain;Western Europe;Elsevier Espana;2005-2020;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
450;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.304;Q4;58;49;91;0;61;65;0.64;0.00;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2020;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medical Laboratory Technology (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q4)"
451;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.304;Q3;36;259;268;12484;410;268;1.55;48.20;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2020;"Analytical Chemistry (Q3); Drug Discovery (Q3); Biochemistry (Q4); Bioengineering (Q4); Molecular Medicine (Q4)"
452;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.302;Q3;27;0;54;0;55;46;1.20;0.00;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019;"Biochemistry (medical) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4)"
453;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.301;Q3;50;100;324;4416;439;322;1.26;44.16;United States;Northern America;Taylor and Francis Ltd.;1996-2020;"Analytical Chemistry (Q3); Pharmaceutical Science (Q3); Biochemistry (Q4); Clinical Biochemistry (Q4)"
454;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.301;Q3;34;25;97;506;85;81;0.57;20.24;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2019;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
455;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.300;Q2;22;0;15;0;27;15;0.00;0.00;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3)"
456;18800156720;Dissolution Technologies;journal;1521298X;0.298;Q3;33;20;73;529;61;62;0.83;26.45;United States;Northern America;Dissolution Technologies Inc;1996-2020;Pharmaceutical Science (Q3)
457;19700174889;Drug Target Insights;journal;11773928;0.297;Q2;12;0;10;0;20;9;2.00;0.00;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2009, 2011-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4)"
458;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.297;Q3;29;6;75;725;93;75;1.02;120.83;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
459;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.296;Q3;23;34;40;1670;65;37;1.56;49.12;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
460;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.294;Q3;18;12;33;758;62;31;1.50;63.17;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Drug Discovery (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
461;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.292;Q3;64;109;271;4931;370;251;1.19;45.24;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2020;"Computer Science Applications (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q4)"
462;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.286;Q3;59;82;201;2027;237;182;1.02;24.72;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2020;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
463;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.286;Q2;38;202;886;7973;1221;881;1.38;39.47;India;Asiatic Region;MediPoeia;2011-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
464;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.285;Q3;27;26;106;1795;62;106;0.68;69.04;United States;Northern America;Current Medicine Group;2007-2020;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
465;4700152612;Current Nanoscience;journal;15734137;0.285;Q3;44;87;211;6470;342;204;1.66;74.37;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Bioengineering (Q4); Nanoscience and Nanotechnology (Q4)"
466;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.281;Q2;22;327;717;9125;847;717;1.23;27.91;India;Asiatic Region;Rasayan Journal;2008-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4)"
467;21810;Farmacia;journal;00148237;0.278;Q2;24;150;447;5468;532;447;1.35;36.45;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
468;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.273;Q3;26;69;152;2018;131;148;0.66;29.25;France;Western Europe;Elsevier Masson;1945, 1947-2020;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
469;21100226424;Toxicology and Environmental Health Sciences;journal;20059752, 22337784;0.272;Q4;15;40;123;1692;137;122;1.20;42.30;South Korea;Asiatic Region;Korean Society of Environmental Risk Assessment and Health Science;2009-2020;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
470;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.271;Q3;9;0;2;0;5;2;2.50;0.00;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010-2016, 2018;"Pharmacology (Q3); Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4)"
471;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.270;Q2;40;106;354;3622;504;352;1.49;34.17;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
472;5800173401;Current Bioactive Compounds;journal;15734072;0.269;Q2;24;133;161;6765;245;156;1.31;50.86;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
473;144963;Drug Discovery Today: Disease Models;journal;17406757;0.268;Q4;26;23;55;1686;41;49;0.93;73.30;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q4); Molecular Medicine (Q4)"
474;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.268;Q3;36;198;296;4771;574;293;1.48;24.10;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011-2020;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Bioengineering (Q4)"
475;19700175096;Pharmacognosy Journal;journal;09753575;0.268;Q3;21;242;610;7806;731;610;1.07;32.26;India;Asiatic Region;EManuscript Technologies;2009-2020;"Drug Discovery (Q3); Pharmacology (Q3)"
476;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.264;Q3;19;24;37;969;33;33;1.14;40.38;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
477;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;0.256;Q3;12;30;105;1431;84;94;0.36;47.70;Italy;Western Europe;Scuola IaD;2012-2019;"Architecture (Q2); Media Technology (Q2); Computer Science Applications (Q3); Human-Computer Interaction (Q3); Pharmacology (Q3); Social Sciences (miscellaneous) (Q3)"
478;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.254;Q4;46;26;128;959;138;116;1.02;36.88;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2020;"Agricultural and Biological Sciences (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
479;23348;Journal of Environmental Biology;journal;02548704;0.247;Q4;48;196;494;7289;394;487;0.72;37.19;India;Asiatic Region;Triveni Enterprises;1988-2020;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
480;21100318814;Pharmaceutical patent analyst;journal;20468954, 20468962;0.247;Q3;15;0;58;0;54;47;1.32;0.00;United Kingdom;Western Europe;Future Science;2012-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4)"
481;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.246;Q3;19;98;321;526;125;179;0.49;5.37;United States;Northern America;Medical Letter Inc.;1965-2020;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
482;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.245;Q3;57;239;383;6657;461;381;1.14;27.85;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2020;Pharmaceutical Science (Q3)
483;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.244;Q3;15;56;154;1734;113;142;0.80;30.96;United Kingdom;Western Europe;John Wiley and Sons Ltd;2010-2020;"Pharmacy (Q2); Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
484;25864;Heterocycles;journal;03855414;0.242;Q3;64;167;656;5366;426;651;0.69;32.13;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2020;"Pharmacology (Q3); Analytical Chemistry (Q4); Organic Chemistry (Q4)"
485;21100902935;Journal of Biologically Active Products from Nature;journal;22311874, 22311866;0.241;Q4;11;41;117;1611;121;117;1.23;39.29;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2020;"Agricultural and Biological Sciences (miscellaneous) (Q3); Complementary and Alternative Medicine (Q3); Plant Science (Q3); Drug Discovery (Q4); Pharmacology (Q4); Toxicology (Q4)"
486;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.241;Q3;14;97;167;3281;180;167;0.95;33.82;Turkey;Middle East;Turkish Pharmacists  Association;2006-2020;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
487;21100228007;Archives of Razi Institute;journal;20089872, 03653439;0.238;Q4;8;46;115;1158;75;115;0.65;25.17;Iran;Middle East;Razi Vaccine and Serum Research Institute;2012-2020;"Veterinary (miscellaneous) (Q3); Immunology and Microbiology (miscellaneous)  (Q4); Toxicology (Q4)"
488;21100909468;Environmental Health and Toxicology;journal;22336567;0.238;Q4;4;22;15;1041;18;13;1.20;47.32;South Korea;Asiatic Region;Korean Society of Environmental Health and Toxicology;2019-2020;"Health, Toxicology and Mutagenesis (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
489;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.238;Q4;23;77;200;844;132;157;0.60;10.96;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2020;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
490;21100924991;Frontiers in Clinical Drug Research - Alzheimer Disorders;book series;22145168, 24518743;0.238;Q3;2;0;7;0;5;1;0.71;0.00;Netherlands;Western Europe;Bentham Science Publishers B.V.;2019;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3); Neurology (clinical) (Q4)"
491;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;0.238;Q3;15;273;839;8860;696;839;0.82;32.45;India;Asiatic Region;International Journal of Applied Pharmaceutics;2011-2020;Pharmaceutical Science (Q3)
492;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.238;Q3;17;69;146;2824;202;140;0.88;40.93;Iran;Middle East;Tabriz University of Medical Sciences;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
493;21100285419;Expert Opinion on Orphan Drugs;journal;21678707;0.237;Q3;18;49;228;4388;151;216;0.65;89.55;United Kingdom;Western Europe;Taylor and Francis Ltd.;2013-2020;"Health Policy (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
494;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.236;Q3;16;8;34;141;27;22;0.91;17.63;United States;Northern America;IPEC-Americas;2010-2020;"Food Science (Q3); Pharmaceutical Science (Q3)"
495;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.234;Q3;5;14;39;322;21;32;0.65;23.00;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2011, 2013-2020;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
496;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.228;Q3;21;28;167;886;143;163;0.76;31.64;Netherlands;Western Europe;Kowsar Publishing Company;2011-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
497;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.226;Q4;29;74;113;3171;126;101;1.30;42.85;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Drug Discovery (Q4); Medicine (miscellaneous) (Q4); Molecular Medicine (Q4)"
498;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.225;Q3;46;818;2538;23930;3004;2538;1.20;29.25;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2020;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
499;130038;Letters in Drug Design and Discovery;journal;15701808;0.223;Q3;33;143;425;5765;467;413;1.12;40.31;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2020;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
500;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.223;Q3;12;6;17;207;11;17;0.44;34.50;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2020;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
501;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.223;Q3;39;315;1184;7730;853;1184;0.65;24.54;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2020;Pharmaceutical Science (Q3)
502;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.221;Q4;44;298;1227;10937;1128;1205;0.96;36.70;United States;Northern America;Sage Publications;2006-2020;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Plant Science (Q4)"
503;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.220;Q4;14;77;214;1962;176;191;0.63;25.48;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2012-2020;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Immunology and Microbiology (miscellaneous)  (Q4); Infectious Diseases (Q4); Microbiology (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
504;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.218;Q4;21;45;125;2812;120;125;0.95;62.49;Chile;Latin America;Universidad de Santiago de Chile;2008-2020;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
505;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.215;Q3;19;32;97;909;105;86;0.92;28.41;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2020;Pharmaceutical Science (Q3)
506;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.214;Q4;5;26;53;862;8;53;0.21;33.15;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2020;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
507;21100928216;Journal of Research in Pharmacy;journal;13090801;0.214;Q3;14;94;275;3359;268;273;0.87;35.73;Turkey;Middle East;Marmara University;2019-2020;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
508;21100398550;Orphan Drugs: Research and Reviews;journal;22306161;0.213;Q3;3;0;4;0;5;4;0.00;0.00;New Zealand;Pacific Region;Dove Medical Press Ltd.;2014-2015, 2017;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
509;21100904334;Natural Volatiles and Essential Oils;journal;21489637;0.212;Q3;3;18;31;604;20;31;0.65;33.56;Turkey;Middle East;Badebio Biotechnololgy Ltd;2018-2020;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Plant Science (Q4)"
510;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.210;Q3;24;137;242;5109;204;240;0.85;37.29;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4)"
511;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996, 15969827;0.209;Q3;36;358;1041;8244;735;1041;0.57;23.03;Nigeria;Africa;Pharmacotherapy Group;2009-2020;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
512;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.208;Q4;7;165;269;5405;134;269;0.54;32.76;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2020;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
513;21100972595;Iranian Journal of Toxicology;journal;22519459, 20082967;0.208;Q4;2;32;32;1001;27;32;0.84;31.28;Iran;Middle East;Arak University of Medical Sciences;2019-2020;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
514;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.206;Q4;27;36;98;1241;101;98;0.91;34.47;United States;Northern America;Taylor and Francis Ltd.;1992-2020;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
515;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.205;Q3;9;0;28;0;18;28;0.75;0.00;New Zealand;Pacific Region;Libertas Academica Ltd.;2010-2018;"Pharmaceutical Science (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
516;21100941292;Frontiers in Clinical Drug Research - Anti Infectives;book series;24523208, 23523212;0.205;Q4;1;6;7;778;4;2;0.57;129.67;Netherlands;Western Europe;Bentham Science Publishers B.V.;2019;"Pharmacology (medical) (Q3); Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4)"
517;21100451405;Natural Products Journal;journal;22103163, 22103155;0.205;Q4;11;72;107;2932;82;104;1.01;40.72;Netherlands;Western Europe;Bentham Science Publishers B.V.;2011-2020;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
518;21100456601;Journal of Pharmacy and Pharmacognosy Research;journal;07194250;0.204;Q3;9;51;125;1789;97;121;0.78;35.08;Chile;Latin America;Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA);2013-2020;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
519;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.201;Q3;19;209;476;6607;389;475;0.76;31.61;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
520;21823;Pharmacia;journal;04280296;0.201;Q3;9;46;85;1247;89;85;0.90;27.11;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2020;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
521;19700181241;Physiology and Pharmacology;journal;17350581;0.200;Q4;11;34;106;1631;72;104;0.62;47.97;Iran;Middle East;Neuroscience Research Center;2009-2020;"Language and Linguistics (Q2); Linguistics and Language (Q2); Pharmacology (Q4); Physiology (Q4)"
522;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.198;Q3;11;39;104;852;70;95;0.46;21.85;United States;Northern America;SAGE Publications Inc.;1989-2020;Pharmaceutical Science (Q3)
523;21211;Pharmacy Education;journal;14772701, 15602214;0.198;Q3;17;28;108;969;56;108;0.46;34.61;Netherlands;Western Europe;;1973-1978, 2002-2020;"Pharmaceutical Science (Q3); Pharmacy (Q3); Education (Q4)"
524;15600154705;EnvironmentAsia;journal;19061714;0.195;Q4;17;46;152;1274;85;152;0.54;27.70;Thailand;Asiatic Region;Thai Society of Higher Eduation Institutes on Environment;2009-2020;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
525;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.194;Q4;9;80;197;1930;56;194;0.32;24.13;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
526;58808;Pharmaceutical Care and Research;journal;16712838;0.192;Q3;8;103;395;1157;37;393;0.08;11.23;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2020;"Pharmaceutical Science (Q3); Pharmacy (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
527;19700174924;Biomedical and Pharmacology Journal;journal;09746242;0.191;Q4;18;242;773;7524;637;773;0.90;31.09;India;Asiatic Region;Oriental Scientific Publishing Company;2009-2020;Pharmacology (Q4)
528;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.191;Q4;31;212;585;5202;371;582;0.62;24.54;United States;Northern America;Springer New York;1967-2020;"Drug Discovery (Q4); Pharmacology (Q4)"
529;19700174978;American Journal of Pharmacy Benefits;journal;21642494, 19454481;0.190;Q3;13;0;32;0;12;23;0.17;0.00;United States;Northern America;Managed Care and Healthcare Communications;2010-2018;"Business and International Management (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Decision Sciences (miscellaneous) (Q4)"
530;21100208082;VacciMonitor;journal;10250298, 1025028X;0.190;Q4;4;20;44;415;13;43;0.32;20.75;Cuba;Latin America;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-2020;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Molecular Medicine (Q4)"
531;21100248874;Dilemas;journal;19835922, 21782792;0.187;Q3;8;41;95;1547;17;93;0.18;37.73;Brazil;Latin America;Universidade Federal do Rio de Janeiro - UFRJ;2013-2020;"Law (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Social Sciences (miscellaneous) (Q3); Sociology and Political Science (Q3)"
532;21758;Prescrire International;journal;11677422;0.186;Q4;12;77;204;850;25;157;0.14;11.04;France;Western Europe;Association Mieux Prescrire;1996-2020;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
533;19446;American Pharmaceutical Review;journal;10998012;0.181;Q3;22;29;234;288;48;203;0.19;9.93;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
534;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.178;Q4;24;47;54;1753;38;51;0.78;37.30;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2020;"Infectious Diseases (Q4); Pharmacology (Q4)"
535;21101016799;Farmakoekonomika;journal;20704933, 20704909;0.177;Q4;3;41;22;1050;14;22;0.64;25.61;Russian Federation;Eastern Europe;IRBIS LLC;2020;"Health Policy (Q4); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)"
536;21100943519;Accounting;journal;23697407, 23697393;0.175;Q3;5;160;21;5349;37;21;1.76;33.43;Canada;Northern America;Growing Science;2018-2020;"Pharmaceutical Science (Q3); Accounting (Q4)"
537;5800173394;Current Drug Therapy;journal;15748855;0.174;Q3;17;53;51;3296;31;49;0.57;62.19;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
538;21100903428;Drug Delivery Letters;journal;2210304X, 22103031;0.174;Q3;2;31;33;1566;20;32;0.61;50.52;Netherlands;Western Europe;Bentham Science Publishers B.V.;2019-2020;"Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4)"
539;21100922188;Farmatsiya i Farmakologiya;journal;23079266, 24132241;0.174;Q3;3;12;35;527;27;35;0.77;43.92;Russian Federation;Eastern Europe;Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute;2019-2020;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
540;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.172;Q3;29;763;2249;26379;1071;2249;0.45;34.57;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2020;"Complementary and Alternative Medicine (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
541;110097;Food and Drug Law Journal;journal;1064590X;0.171;Q4;19;0;43;0;29;42;0.68;0.00;United States;Northern America;Food and Drug Law Institute;1992-2018;"Law (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)"
542;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.171;Q3;9;39;34;1315;21;34;0.59;33.72;Jordan;Middle East;The University of Jordan;2009-2020;Pharmaceutical Science (Q3)
543;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.170;Q3;42;80;469;2693;253;468;0.27;33.66;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2020;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
544;22908;Chinese Pharmacological Bulletin;journal;10011978;0.169;Q4;16;111;1023;1965;224;1022;0.23;17.70;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2019;Pharmacology (Q4)
545;18633;Herba Polonica;journal;00180599;0.169;Q4;4;19;49;709;36;49;0.73;37.32;Poland;Eastern Europe;Instytut Roslin i Przetworow Zielarskich;1973-1979, 2018-2020;"Complementary and Alternative Medicine (Q3); Ecology, Evolution, Behavior and Systematics (Q4); Pharmacology (Q4); Plant Science (Q4)"
546;80593;Journal of Medicinal Plants;journal;16840240;0.168;Q4;21;96;192;3517;89;191;0.43;36.64;Iran;Middle East;;2004-2020;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
547;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685, 19054637;0.167;Q3;11;36;90;1240;51;90;0.62;34.44;Thailand;Asiatic Region;Thai Journal of Pharmaceutical Sciences;2009-2020;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
548;20826;Vojenske Zdravotnicke Listy;journal;03727025;0.164;Q3;2;25;49;850;9;37;0.18;34.00;Czech Republic;Eastern Europe;Vojenska Lekarska Akademie;1948-1951, 1961, 1963, 1965, 1973-1992, 2018-2020;"Emergency Medical Services (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Emergency Medicine (Q4); Immunology and Microbiology (miscellaneous)  (Q4); Public Health, Environmental and Occupational Health (Q4); Veterinary (miscellaneous) (Q4)"
549;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.163;Q4;37;5;75;116;46;75;0.48;23.20;United States;Northern America;Old City Publishing;1996, 2002-2020;"Cancer Research (Q4); Drug Discovery (Q4); Pharmacology (Q4)"
550;21100820896;Journal of Advanced Pharmacy Education and Research;journal;22493379;0.162;Q3;7;85;269;2282;112;269;0.35;26.85;India;Asiatic Region;"Society of Pharmaceutical Education &amp; Research [SPER]";2015, 2017-2020;"Pharmaceutical Science (Q3); Pharmacy (Q3); Education (Q4)"
551;20564;Ceska a Slovenska Farmacie;journal;12107816;0.159;Q3;16;31;85;1090;42;84;0.54;35.16;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2020;Pharmaceutical Science (Q3)
552;4700152607;Current Enzyme Inhibition;journal;15734080;0.157;Q4;17;24;61;1475;28;56;0.40;61.46;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2020;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
553;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.157;Q4;17;0;25;0;17;23;1.20;0.00;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
554;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.155;Q4;51;67;179;1578;52;165;0.25;23.55;India;Asiatic Region;Scientific Scholar;1959-2020;"Pharmacology (Q4); Physiology (Q4); Physiology (medical) (Q4)"
555;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;0.155;Q3;7;35;100;1542;57;100;0.58;44.06;Iran;Middle East;Wolters Kluwer Medknow Publications;2012-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4); Pharmacology (medical) (Q4)"
556;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.154;Q4;19;29;61;948;28;61;0.53;32.69;India;Asiatic Region;Informatics Publishing Limited;2002-2020;Pharmacology (Q4)
557;19700170837;Vitae;journal;21452660, 01214004;0.154;Q3;13;10;45;462;21;37;0.33;46.20;Colombia;Latin America;Universidad de Antioquia;2009-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4)"
558;21100867470;Indonesian Journal of Pharmacy;journal;23389486, 23389427;0.153;Q3;6;27;95;819;61;95;0.56;30.33;Indonesia;Asiatic Region;Universitas Gadjah Mada - Faculty of Pharmacy;2016-2020;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (medical) (Q4)"
559;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.152;Q3;16;23;61;760;17;51;0.26;33.04;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
560;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0.152;Q3;32;312;749;13447;349;749;0.48;43.10;China;Asiatic Region;Zhonghua Yixuehui Zazhishe;1960, 1962-1966, 1979-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
561;21100804474;European Pharmaceutical Journal;journal;24536725;0.151;Q3;7;11;35;303;18;35;0.15;27.55;Germany;Western Europe;de Gruyter;2016-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
562;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.150;Q3;16;27;71;1325;31;71;0.47;49.07;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2020;Pharmaceutical Science (Q3)
563;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.150;Q3;47;1;81;18;44;80;0.53;18.00;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
564;22934;Chinese Pharmaceutical Journal;journal;10012494;0.149;Q3;21;325;1047;7585;284;1047;0.28;23.34;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2020;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
565;17300154738;Current Trends in Biotechnology and Pharmacy;journal;22307303, 09738916;0.149;Q3;13;46;102;1463;41;102;0.48;31.80;India;Asiatic Region;Association of Biotechnology and Pharmacy;2009-2020;"Pharmaceutical Science (Q3); Biotechnology (Q4); Drug Discovery (Q4)"
566;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.144;Q3;10;37;46;1465;14;46;0.23;39.59;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2020;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
567;21100858119;Pharmaceutical Sciences Asia;journal;25868195, 25868470;0.144;Q3;3;39;80;1091;34;80;0.42;27.97;Thailand;Asiatic Region;Mahidol University - Faculty of Pharmacy;2017-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
568;24097;Journal of the Indian Chemical Society;journal;00194522;0.142;Q4;32;176;335;4772;120;335;0.45;27.11;India;Asiatic Region;Indian Chemical Society;1973-1985, 1987-1991, 1996-2020;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
569;130170;Phytotherapie;journal;17652847, 16248597;0.142;Q4;16;49;207;1548;58;186;0.20;31.59;France;Western Europe;Springer Paris;2005-2019;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
570;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.142;Q3;8;34;96;823;5;85;0.09;24.21;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2020;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
571;21100237602;Journal of Pharmacy and Nutrition Sciences;journal;19275951, 22233806;0.141;Q4;10;43;64;2190;36;64;0.54;50.93;Canada;Northern America;;2011-2019;"Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
572;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.141;Q3;41;194;634;4177;190;530;0.28;21.53;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2020;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
573;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.140;Q4;15;746;2481;24089;711;2481;0.26;32.29;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2020;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
574;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.140;Q4;12;38;81;1045;28;81;0.32;27.50;Iran;Middle East;Iranian Association of Pharmaceutical Scientists;2010-2014, 2016-2020;"Bioengineering (Q4); Pharmaceutical Science (Q4)"
575;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.140;Q4;13;18;43;0;16;43;0.19;0.00;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2020;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
576;21798;Farmaceutski Glasnik;journal;00148202;0.139;Q4;6;63;243;970;5;208;0.01;15.40;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2020;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
577;23171;Korean Journal of Pharmacognosy;journal;02533073;0.139;Q4;16;45;144;1314;39;144;0.27;29.20;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2020;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
578;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.138;Q4;12;92;274;2546;73;273;0.33;27.67;China;Asiatic Region;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-2020;Pharmaceutical Science (Q4)
579;13000154717;Current Topics in Toxicology;journal;09728228;0.137;Q4;6;23;29;819;9;29;0.29;35.61;India;Asiatic Region;Research Trends;2007-2009, 2011-2020;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
580;9100153105;Current Topics in Pharmacology;journal;09724559;0.135;Q4;6;14;35;591;8;35;0.26;42.21;India;Asiatic Region;Research Trends;2006-2019;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
581;21100967064;Defence Life Science Journal;journal;24560537;0.135;Q4;3;43;37;1473;15;36;0.41;34.26;India;Asiatic Region;"Defence Scientific Information &amp; Documentation Centre (DESIDOC)";2019-2020;"Agricultural and Biological Sciences (miscellaneous) (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
582;19700175149;African Journal Biomedical Research;journal;11195096;0.134;Q4;17;93;141;2652;36;136;0.20;28.52;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2019;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
583;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.134;Q4;9;40;120;1251;42;120;0.41;31.28;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2020;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
584;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.134;Q4;24;0;3;0;1;3;0.00;0.00;United States;Northern America;Lumitext Publishing;2009-2017;"Molecular Biology (Q4); Pharmaceutical Science (Q4)"
585;21867;Geneesmiddelenbulletin;journal;03044629;0.133;Q4;6;19;74;519;6;64;0.12;27.32;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
586;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.133;Q4;9;104;184;2634;78;184;0.47;25.33;India;Asiatic Region;International Journal of Drug Delivery Technology;2011-2012, 2014-2020;Pharmaceutical Science (Q4)
587;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;0.133;Q4;25;349;1064;8634;260;1064;0.24;24.74;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2020;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
588;21101005186;Research Results in Pharmacology;journal;2658381X;0.132;Q4;7;42;77;1565;88;76;1.14;37.26;Russian Federation;Eastern Europe;Belgorod State National Research University;2018-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
589;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.131;Q4;10;74;201;0;60;176;0.35;0.00;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2020;"Pharmacology (nursing) (Q2); Pharmacy (Q3); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
590;19700174658;Regulatory Rapporteur;trade journal;17428955;0.130;Q4;5;75;210;399;14;137;0.06;5.32;United Kingdom;Western Europe;TOPRA;2010-2020;"Pharmacy (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
591;19408;Actualites Pharmaceutiques;journal;05153700;0.129;Q4;5;186;537;1504;27;433;0.03;8.09;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
592;21100936542;Biomedical and Biopharmaceutical Research;journal;21822379, 21822360;0.129;Q4;1;20;21;490;6;20;0.29;24.50;Portugal;Western Europe;ALIES;2019-2020;"Pharmacy (Q3); Food Science (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
593;19700174961;BioProcess International;trade journal;15426319;0.129;Q4;22;0;39;0;6;39;0.00;0.00;United States;Northern America;PJB Publications Ltd.;2009-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Drug Discovery (Q4)"
594;144879;Toxicology International;journal;09716580;0.129;Q4;26;18;61;566;15;61;0.14;31.44;India;Asiatic Region;Society of Toxicology India;2005-2018, 2020;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
595;22358;U.S. Pharmacist;trade journal;01484818;0.129;Q4;7;102;356;1303;56;232;0.16;12.77;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2020;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
596;21100829925;HiSTOReLo;journal;2145132X;0.128;Q4;2;24;72;1002;8;61;0.12;41.75;Colombia;Latin America;Universidad Nacional de Colombia;2013-2020;"History (Q2); Cultural Studies (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Social Sciences (miscellaneous) (Q4)"
597;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.128;Q4;10;74;163;2671;37;162;0.27;36.09;Netherlands;Western Europe;IOS Press;2010-2020;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
598;20065;BioPharm International;trade journal;1542166X, 19391862;0.127;Q4;27;101;357;583;38;136;0.03;5.77;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Biotechnology (Q4); Pharmaceutical Science (Q4)"
599;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.127;Q4;15;43;449;841;61;447;0.13;19.56;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
600;21100933230;Tropical Journal of Natural Product Research;journal;26160692, 26160684;0.127;Q4;4;189;204;7188;65;197;0.32;38.03;Nigeria;Africa;Faculty of Pharmacy, University of Benin;2017-2020;"Analytical Chemistry (Q4); Biochemistry (Q4); Complementary and Alternative Medicine (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
601;5800179590;Pharmacologyonline;journal;18278620;0.126;Q4;25;83;271;2275;62;270;0.22;27.41;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2020;"Drug Discovery (Q4); Pharmacology (Q4)"
602;21100932762;Advanced Therapeutics;journal;23663987;0.125;Q4;0;0;1;0;0;1;0.00;0.00;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2019;"Biochemistry (medical) (Q4); Genetics (clinical) (Q4); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
603;21100854242;International Nano Letters;journal;22285326, 20089295;0.125;Q4;1;0;1;0;0;1;0.00;0.00;United States;Northern America;Springer Science + Business Media;2014, 2019;"Bioengineering (Q4); Biomedical Engineering (Q4); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
604;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;0.125;Q4;8;47;144;2846;98;1;0.73;60.55;United States;Northern America;Humana Press;2008, 2012, 2014-2020;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
605;19700174997;ONdrugDelivery;trade journal;2049145X, 20491468;0.125;Q4;6;72;360;432;13;231;0.03;6.00;United Kingdom;Western Europe;Frederick Furness Publishing;2009-2020;Pharmaceutical Science (Q4)
606;21100932743;Pharmaceutical Technology in Hospital Pharmacy;journal;2365242X, 23652411;0.125;Q4;0;0;1;0;0;1;0.00;0.00;Germany;Western Europe;Walter de Gruyter GmbH;2019;"Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
607;73076;Drug Discovery World;journal;14694344;0.123;Q4;12;0;52;0;4;51;0.08;0.00;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
608;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.123;Q4;18;98;291;1537;40;260;0.16;15.68;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2020;Pharmacology (Q4)
609;17700156303;Neuromethods;book series;19406045, 08932336;0.123;Q4;20;112;503;5808;213;12;0.46;51.86;United States;Northern America;Humana Press;2009-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Neuroscience (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Psychiatry and Mental Health (Q4)"
610;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.123;Q4;13;63;180;760;5;122;0.03;12.06;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2020;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
611;21100913634;Iraqi Journal of Pharmaceutical Sciences;journal;16833597, 25213512;0.122;Q4;1;48;42;1784;12;42;0.29;37.17;Iraq;Middle East;University of Baghdad - College of Pharmacy;2019-2020;"Analytical Chemistry (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
612;22375;Indian Drugs;journal;0019462X;0.121;Q4;31;97;368;2401;42;346;0.13;24.75;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2020;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
613;22906;Journal of China Pharmaceutical University;journal;10005048;0.121;Q4;14;65;292;1727;41;292;0.14;26.57;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2019;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
614;21100878895;10th International Conference on Environmental Pollution and Public Health, EPPH 2018;conference and proceedings;-;0.119;-;1;0;8;0;3;7;0.38;0.00;China;Asiatic Region;;2018;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
615;21100905494;Analytical Science and Technology;journal;12250163, 22888985;0.119;Q4;1;26;29;596;3;29;0.10;22.92;South Korea;Asiatic Region;Korea Society of Analytical Science;2019-2020;"Agronomy and Crop Science (Q4); Analytical Chemistry (Q4); Environmental Chemistry (Q4); Food Science (Q4); Materials Chemistry (Q4); Pharmacology (Q4)"
616;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.119;Q4;12;7;113;218;14;111;0.10;31.14;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2019;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
617;19700175034;Pharmaceutical Processing;trade journal;10499156;0.118;Q4;2;0;49;0;3;4;0.08;0.00;United States;Northern America;Advantage Business Media;2009-2018;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
618;73430;Pharmaceutical Technology;journal;15432521;0.118;Q4;37;141;689;708;60;209;0.07;5.02;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2020;"Biophysics (Q4); Pharmaceutical Science (Q4)"
619;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.116;Q4;11;68;319;2190;44;316;0.11;32.21;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2019;"Pharmacology (Q4); Toxicology (Q4)"
620;21265;Drugs of the Future;journal;03778282;0.115;Q4;43;75;251;2235;32;250;0.14;29.80;Spain;Western Europe;Prous Science;1978-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
621;21100944623;Environmental Arsenic in a ChangingWorld - 7th International Congress and Exhibition Arsenic in the Environment, 2018;conference and proceedings;-;0.115;-;2;0;213;0;15;207;0.07;0.00;United Kingdom;Western Europe;;2018;"Health, Toxicology and Mutagenesis; Toxicology"
622;19700174925;European Pharmaceutical Review;trade journal;13608606;0.115;Q4;7;0;143;0;22;140;0.04;0.00;United Kingdom;Western Europe;Russell Publishing LLC;2009-2019;"Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
623;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0.115;Q4;20;2582;1016;50294;242;1016;0.25;19.48;India;Asiatic Region;Indian Journal of Forensic Medicine and Toxicology;2008-2020;"Health, Toxicology and Mutagenesis (Q4); Law (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
624;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.114;Q4;7;84;199;2087;48;198;0.16;24.85;India;Asiatic Region;In-IJPQA;2011, 2013-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
625;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.113;Q4;3;8;40;73;8;40;0.30;9.13;Azerbaijan;Eastern Europe;Azerbaijan Medical University;2009-2019;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
626;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.113;Q4;6;0;17;0;4;16;0.00;0.00;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
627;21100853016;Antibodies;journal;20734468;0.112;Q4;6;0;2;0;0;2;0.00;0.00;Switzerland;Western Europe;MDPI AG;2014-2017;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4)"
628;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.112;Q4;15;46;277;646;57;277;0.22;14.04;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2019;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
629;22514;Japanese Journal of Chemotherapy;journal;13407007;0.112;Q4;12;37;95;757;7;95;0.06;20.46;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
630;19700174922;Chinese Journal of New Drugs;journal;10033734;0.111;Q4;11;453;1516;10120;137;1516;0.10;22.34;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2020;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
631;19700171709;Arhiv za Farmaciju;journal;00041963;0.110;Q4;3;25;71;1068;2;71;0.02;42.72;Serbia;Eastern Europe;Farmaceutsko Drustvo Srbije;1954-1955, 2009-2020;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
632;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;0.109;Q4;22;0;8;0;2;7;0.00;0.00;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Biochemistry (medical) (Q4); Drug Discovery (Q4); Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Medicine (miscellaneous) (Q4)"
633;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.108;Q4;18;0;5;0;3;3;0.50;0.00;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Strategy and Management (Q4)"
634;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.108;Q4;5;33;85;850;4;81;0.05;25.76;Czech Republic;Eastern Europe;SOLEN S.R.O.;2009-2020;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
635;21102;Pharmaceutical Journal;journal;00316873;0.108;Q4;28;0;72;0;2;21;0.00;0.00;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
636;19700174940;SA Pharmaceutical Journal;journal;10151362;0.108;Q4;7;34;218;359;18;143;0.08;10.56;South Africa;Africa;Medpharm Publications;2009-2020;Pharmaceutical Science (Q4)
637;5800207507;Side Effects of Drugs Annual;book series;03786080;0.108;Q4;6;43;148;2116;42;3;0.33;49.21;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
638;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.107;Q4;13;28;70;808;23;57;0.41;28.86;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2015, 2020;"Computer Science Applications (Q4); Drug Discovery (Q4)"
639;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.107;Q4;9;0;31;0;3;29;0.05;0.00;Netherlands;Western Europe;IOS Press;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
640;5200152604;Pharma Times;journal;00316849;0.107;Q4;11;4;170;34;8;109;0.07;8.50;India;Asiatic Region;Indian Pharmaceutical Association;2006-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
641;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.106;Q4;4;198;359;6036;17;354;0.05;30.48;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2020;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
642;19700175108;Drug Delivery System;journal;18812732, 09135006;0.106;Q4;8;50;183;824;8;118;0.05;16.48;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2020;Pharmaceutical Science (Q4)
643;21100982469;Frontiers in Clinical Drug Research - Anti Allergy Agents;book series;22146938, 24523194;0.106;Q4;0;0;7;0;0;4;0.00;0.00;Netherlands;Western Europe;Bentham Science Publishers B.V.;2019;"Drug Discovery (Q4); Immunology and Allergy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
644;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.106;Q4;7;10;31;460;1;31;0.05;46.00;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
645;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.106;Q4;6;44;161;693;10;150;0.08;15.75;India;Asiatic Region;Punjab Academy of Forensic Medicine and Toxicology;2011-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
646;21100847105;2017 International Conference on Environmental Pollution and Public Health, EPPH 2017;conference and proceedings;-;0.105;-;1;0;6;0;1;5;0.00;0.00;United States;Northern America;;2017;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
647;19700174886;Arzneimitteltherapie;journal;07236913;0.105;Q4;6;137;483;1137;7;193;0.02;8.30;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2020;"Pharmacology (medical) (Q4); Pharmacology (nursing) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
648;19700174992;European Journal of Oncology Pharmacy;journal;17833914;0.105;Q4;4;0;21;0;6;16;0.50;0.00;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology (Q4); Pharmacology (Q4)"
649;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.105;Q4;7;38;107;574;6;104;0.04;15.11;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
650;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.105;Q4;6;109;673;2112;37;673;0.04;19.38;China;Asiatic Region;Jilin University Press;2005-2020;Pharmacology (Q4)
651;21100201517;RSC Drug Discovery Series;book series;20413203, 20413211;0.105;Q4;9;12;256;1740;57;36;0.25;145.00;United Kingdom;Western Europe;Royal Society of Chemistry;2010, 2014-2020;Drug Discovery (Q4)
652;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.104;Q4;5;126;363;2651;17;363;0.04;21.04;China;Asiatic Region;China Pharmaceutical University;2007-2020;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
653;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;09644679;0.104;Q4;6;0;12;0;0;6;0.00;0.00;United Kingdom;Western Europe;Euromed Communications;2010-2016, 2018-2019;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
654;21100986051;Cancer Drug Discovery and Development;book series;21969906, 21969914;0.103;Q4;5;14;100;1651;44;7;0.55;117.93;United States;Northern America;Springer New York;2015, 2017-2020;"Cancer Research (Q4); Drug Discovery (Q4); Oncology (Q4)"
655;21101020026;Frontiers in Anti-infective Drug Discovery;book series;1879663X, 24519162;0.103;Q4;0;1;8;141;0;7;0.00;141.00;Netherlands;Western Europe;Bentham Science Publishers B.V.;2019;"Drug Discovery (Q4); Infectious Diseases (Q4); Molecular Medicine (Q4)"
656;21100881509;Journal of International Pharmaceutical Research;journal;16740440;0.103;Q4;6;168;187;5236;13;187;0.04;31.17;China;Asiatic Region;Editorial office of Journal of International Pharmaceutical Research;2010-2011, 2013-2020;Pharmaceutical Science (Q4)
657;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.103;Q4;9;0;9;0;1;9;0.00;0.00;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q4)
658;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.102;Q4;11;7;11;135;0;11;0.00;19.29;India;Asiatic Region;Anil Aggrawal;2000-2020;"Law (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
659;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.102;Q4;8;24;12;827;0;12;0.00;34.46;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2020;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
660;17600155051;Drug Development and Delivery;trade journal;1944818X, 15372898;0.102;Q4;11;74;198;370;7;107;0.05;5.00;United States;Northern America;Drug Delivery Technology;2009-2020;Pharmaceutical Science (Q4)
661;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.102;Q4;7;0;10;0;0;10;0.00;0.00;India;Asiatic Region;Medicinal and Aromatic Plants Association of India;2010-2019;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
662;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.102;Q4;5;3;27;82;1;27;0.00;27.33;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2018;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
663;21100900318;Pharmaceutical Discovery, Development and Manufacturing Forum 2018 - Core Programming Area at the 2018 AIChE Annual Meeting;conference and proceedings;-;0.102;-;0;0;14;0;0;13;0.00;0.00;United States;Northern America;;2018;"Organic Chemistry; Pharmaceutical Science"
664;13718;Pharmaceutical Engineering;journal;02738139;0.102;Q4;16;0;96;0;5;54;0.07;0.00;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q4)
665;21127;Pharmaceutical Technology Europe;journal;01646826;0.102;Q4;17;18;309;122;10;256;0.04;6.78;United States;Northern America;Advanstar Communications Inc.;1998-2019;Pharmaceutical Science (Q4)
666;19700175580;PharmacoVigilance Review;journal;17526752;0.102;Q4;2;0;20;0;1;15;0.08;0.00;United Kingdom;Western Europe;Euromed Communications;2010-2019;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
667;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.102;Q4;18;0;567;0;16;539;0.03;0.00;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q4)
668;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.101;Q4;7;3;19;79;0;17;0.00;26.33;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
669;21238;Drug Topics;journal;19378157, 00126616;0.101;Q4;7;129;504;48;3;30;0.00;0.37;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2020;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
670;21100202747;GMP Review;trade journal;14764547;0.101;Q4;2;19;43;38;0;23;0.00;2.00;United Kingdom;Western Europe;Euromed Communications Ltd;2011-2015, 2017-2019;Pharmaceutical Science (Q4)
671;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.101;Q4;41;1;39;50;2;31;0.03;50.00;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q4); Toxicology (Q4)"
672;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.101;Q4;10;0;26;0;2;24;0.00;0.00;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
673;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.101;Q4;9;3;34;559;0;32;0.00;186.33;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008, 2010-2011, 2013-2017, 2020;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
674;19700174966;Pharmakeftiki;journal;22413081, 11054999;0.101;Q4;4;9;42;345;2;38;0.05;38.33;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2020;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
675;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.101;Q4;16;16;157;617;2;64;0.14;38.56;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2017;Pharmaceutical Science (Q4)
676;20628;Circular Farmaceutica;journal;00097314;0.100;Q4;2;11;84;118;0;73;0.00;10.73;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2019;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
677;19700173109;Contract Pharma;trade journal;15443469, 23806559;0.100;Q4;3;0;143;0;0;143;0.00;0.00;United States;Northern America;Contract Pharma;2009-2018;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
678;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.100;Q4;5;0;96;0;0;81;0.00;0.00;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
679;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.100;Q4;8;0;100;0;0;98;0.00;0.00;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
680;13637;Manufacturing Chemist;trade journal;02624230;0.100;Q4;6;82;215;104;0;215;0.00;1.27;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2020;Pharmaceutical Science (Q4)
681;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.100;Q4;3;0;53;0;0;53;0.00;0.00;United Kingdom;Western Europe;Samedan Ltd;2009-2016, 2018-2019;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
682;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.100;Q4;6;0;135;0;1;119;0.00;0.00;United States;Northern America;Russell Publishing LLC;2010-2018;"Health Policy (Q4); Pharmaceutical Science (Q4)"
683;21142;Pharmaceutisch Weekblad;journal;00316911;0.100;Q4;9;365;1354;0;7;701;0.00;0.00;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
684;21243;Pharmacy Times;trade journal;00030627;0.100;Q4;8;175;537;816;0;104;0.00;4.66;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2020;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
685;21716;Pharmazeutische Zeitung;journal;00317136;0.100;Q4;7;43;2374;0;2;1107;0.00;0.00;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
686;20572;PZ Prisma;journal;09455566;0.100;Q4;5;35;102;691;0;90;0.00;19.74;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2019;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
687;21101018620;Adverse Drug Reactions Journal;journal;10085734;;-;1;193;0;2785;0;0;0.00;14.43;China;Asiatic Region;Chinese Medical Association;2020;"Pharmacology; Pharmacology (medical)"
688;21100981214;Bioengineering and Translational Medicine;journal;23806761;;-;5;44;0;2366;0;0;0.00;53.77;United States;Northern America;"John Wiley &amp; Sons Inc.";2020;"Biomedical Engineering; Biotechnology; Pharmaceutical Science"
689;21101012656;Drug Development and Registration;journal;26585049, 23052066;;-;2;76;0;1339;0;0;0.00;17.62;Russian Federation;Eastern Europe;Center of Pharmaceutical Analytics;2020;"Drug Discovery; Pharmaceutical Science"
690;21100202909;Drug Invention Today (discontinued);journal;09757619;;-;15;444;2052;9698;673;2052;0.32;21.84;India;Asiatic Region;Association of Pharmaceutical Innovators;2012-2020;Drug Discovery
691;21101017910;International Journal of Medical Toxicology and Forensic Medicine;journal;22518770, 22518762;;-;1;57;0;1291;0;0;0.00;22.65;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2020;"Pathology and Forensic Medicine; Toxicology"
692;19700174645;International Journal of Pharmaceutical Research (discontinued);journal;09752366;;-;17;2506;984;71711;639;983;0.67;28.62;India;Asiatic Region;Advanced Scientific Research;2010-2020;"Pharmaceutical Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
693;19700188319;International Journal of Pharmaceutical Sciences Review and Research (discontinued);journal;0976044X;;-;30;1;0;29;0;0;0.00;29.00;India;Asiatic Region;Global Research Online;2010-2016;Pharmaceutical Science
694;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;;-;36;1;254;31;281;253;0.81;31.00;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018;Pharmacology
695;19700175778;International Journal of Research in Pharmaceutical Sciences (discontinued);journal;09757538;;-;19;1657;922;36895;528;921;0.60;22.27;India;Asiatic Region;"JK Welfare &amp; Pharmascope Foundation";2010-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
696;21100920227;Journal of Critical Reviews (discontinued);journal;23945125;;-;12;2906;131;65194;166;131;1.27;22.43;India;Asiatic Region;Innovare Academics Sciences Pvt. Ltd;2019-2020;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
697;19700200708;Journal of Global Pharma Technology (discontinued);journal;09758542;;-;14;353;1215;9682;424;1215;0.33;27.43;India;Asiatic Region;Journal of Global Pharma Technology;2010-2020;Pharmaceutical Science
698;19700174933;Journal of Pharmaceutical Sciences and Research (discontinued);journal;09751459;;-;29;7;1309;333;892;1294;0.65;47.57;India;Asiatic Region;;2009-2018;Pharmaceutical Science
699;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;;-;19;7;25;793;49;0;2.25;113.29;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2020;"Medicine (miscellaneous); Molecular Medicine; Pharmaceutical Science; Pharmacology"
700;25197;Revista de Toxicologia (discontinued);journal;02127113;;-;11;7;32;221;5;11;0.00;31.57;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017;Toxicology
701;19700194018;Russian Journal of Biopharmaceuticals (discontinued);journal;20738099;;-;5;26;169;423;29;169;0.11;16.27;Russian Federation;Eastern Europe;Folium Publishing Company;2011-2020;"Bioengineering; Drug Discovery"
702;21100944629;Selenium Research for Environment and Human Health: Perspectives, Technologies and Advancements - Proceedings of the 6th International Conference on Selenium in the Environment and Human Health, 2019;conference and proceedings;-;;-;1;87;0;531;0;0;0.00;6.10;United Kingdom;Western Europe;;2020;"Health, Toxicology and Mutagenesis; Toxicology"
703;19700201140;Systematic Reviews in Pharmacy (discontinued);journal;09758453, 09762779;;-;25;1468;112;48675;597;112;5.37;33.16;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2020;Pharmaceutical Science
